1. Introduction {#sec1}
===============

Quaternary α-hydroxy carbonyl compounds are an important scaffold in many natural products and small molecule drugs.^[@ref1]^ In particular, the C3-hydroxy 2-oxindole skeleton remains fascinating to the synthetic chemist as it constitutes a key structural feature in natural products ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) such as TMC-95s, Donaxaridine, Arundaphine, Maremycins, etc.^[@ref2]^ A pivotal step in the synthesis of such hydroxyl oxindole natural products is the construction of quaternary α-hydroxy 2-oxindole. Over the past decade, several synthetic approaches have been developed for the synthesis of quaternary α-hydroxy carbonyl compounds, centered on the isatin/indole/2-oxindole as the starting material,^[@ref3]^ which require multistep syntheses involving stepwise C3-substitution and subsequent C--H hydroxylation. However, the direct synthesis of quaternary α-hydroxyl amides from amides using alcohols as alkylating reagents has never been explored. In recent developments on synthetic methodologies, cooperative nitrogen- and phosphine-based donor ligands in a well-defined metal catalyst for borrowing hydrogen strategy have emerged as green and atom economical alternatives for the α-alkylation of ketones,^[@ref4]^ which generate water as the only by-product.

![Bioinspired Natural Products/Drugs.](ao-2017-01152y_0002){#fig1}

In this lineup, N-heterocyclic carbene (NHC) is a synthetically accessible and highly useful ligand in various catalytic transformations,^[@ref5]^ and it has been proven to be an effective catalyst for alkylation reactions limited to only ketone and amine substrates. For instance, a recent report by Glorius et al. delineated an in situ generated Ru-NHC catalyst for the mono and double α-alkylation of ketones.^[@ref6]^ Huynh et al. described an important application of Ru-NHC as a very effective and easily accessible catalyst for the amination reactions using alcohols under the borrowing hydrogen concept.^[@ref7]^ Furthermore, Madsen et al. and Hong et al. reported Ru-NHC catalyzed direct amide syntheses using alcohols and amines. Very limited reports exist for the α-alkylation of amides^[@ref8]^ catalyzed by air sensitive cooperative pincer-type complexes.

Likewise, C--H hydroxylation of carbonyl compounds, considered as an important organic transformation to generate hydroxyl functional groups in many natural products, has been well studied as discrete reaction steps in many multistep syntheses.^[@ref9],[@ref10]^ Although two discrete reaction steps for the C--H alkylation and hydroxylation are known in the literature, the Ru-NHC catalyzed one pot C--H alkylation and C--H hydroxylation of amide to get quaternary α-hydroxy ketones/amides are not known in the literature. Further, the synthesis of Donaxaridine, encompassing quaternary α-hydroxy amide functionality, comprises multistep and longer synthetic routes. The one pot condition for the synthesis of organic scaffolds, in which many bond formations occur without isolation of the intermediates, has attracted synthetic chemists in the last few decades.^[@ref11]^ Hence, it is envisioned that developing a one pot tandem approach for C3-alkylated 3-hydroxyindolin-2-one from 2-oxindole will be advantageous over a multistep route for synthesizing Donaxaridine and related natural products.

Recently, we reported^[@ref12]^ the Ru-PNN catalyzed alkylation and hydroxylation of amides using alcohols. This catalyst requires an inert atmosphere condition and proceeds via the addition of water to the Ru--alkoxy indole intermediates to afford the C3-hydroxy 2-oxindole. Furthermore, Ru-PNN catalyst contains an electron-rich phosphine ligand backbone, which is highly air sensitive. In continuation of our efforts to identify a simple phosphine-free catalytic system, herein, we demonstrated an air stable and well-defined Ru-NHC catalyst for the domino α-alkylation of unactivated amides and 2-oxindole using alcohols, and its subsequent exposure to aerobic oxidation to get quaternary α-hydroxy amides ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). In contrast to the known α-C--H hydroxylation of ketones using oxidants and bases,^[@ref10]^ the Ru-NHC catalyzed reaction of 2-oxindole with alcohols underwent domino dehydrogenation--condensation--reduction-C--H hydroxylation processes, without the use of any additional oxidant, in a one pot condition. To the best of our knowledge, the double functionalization (C--H alkylation and aerobic C--H hydroxylation) at the α-position of 2-oxindole using a well-defined Ru-NHC catalyst has not studied in the literature ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Scope of the Present Work](ao-2017-01152y_0007){#sch1}

2. Results and Discussion {#sec2}
=========================

We performed the initial optimization for the α-alkylation of *N*,*N*-dimethylacetamide with benzyl alcohol using Ru-NHC catalyst as a preferred model reaction. Heating a toluene solution to 140 °C containing *N*,*N*-dimethylacetamide, benzyl alcohol, 0.1--0.5 equiv of KO*t*Bu, and 1.0 mol % of catalyst **2a** results in only benzyl benzoate as the product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1--3). Different conditions were probed for this reaction ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}); for example, a decrease in temperature with a substoichiometric amount of KO*t*Bu results in a lower conversion and yield of product **1a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 4 and 5). Increasing the temperature (140 °C) with a substoichiometric amount of KO*t*Bu to *N*,*N*-dimethylacetamide provided 48% of **1a** with complete conversion of the benzyl alcohol ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 6). Significant improvement was obtained upon heating the reaction mixture under neat conditions at 90 °C to afford **1a** in 57% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 7). Best optimized conditions were achieved by heating the reaction mixture under neat conditions at 140 °C to furnish **1a** in 71% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 8).

###### Optimization of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-01152y_0005){#fx1}

  entry                               KO*t*Bu/amide (equiv)   temp (°C)   conv of alcohol (%)[b](#t1fn2){ref-type="table-fn"}   isolated yield of amide **1a** (%)
  ----------------------------------- ----------------------- ----------- ----------------------------------------------------- ------------------------------------
  1                                   0:1 or 0.1:1            140         0                                                     no reaction
  2                                   0.2:1                   140         70                                                    benzyl benzoate
  3                                   0.5:1                   140         25                                                    benzyl benzoate
  4                                   1:1                     90          47                                                    amide **1a** (21)
  5                                   2:2                     90          72                                                    amide **1a** (40)
  6                                   2:2                     140         100                                                   amide **1a** (48)
  7[c](#t1fn3){ref-type="table-fn"}   1.3:23                  90          60                                                    amide **1a** (57)
  8[c](#t1fn3){ref-type="table-fn"}   1.3:23                  140         80                                                    amide **1a** (71)

Reaction conditions: Complex **2a** (0.01 mmol), benzyl alcohol (1.0 mmol), *N*,*N*-dimethylacetamide (see table), KO*t*Bu (see table), and toluene (1 mL) were heated in a sealed tube for 16 h.

Gas chromatography (GC) conversion using mesitylene as internal standard.

Neat conditions.

Once the conditions were optimized, we set out to investigate the reaction scope. A range of Ru-NHC catalysts and alcohols were investigated under the optimized conditions ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). First, the α-alkylation reaction in the presence of 1.0 mol % complex **2b** afforded the product **1a** as the sole product in 56% yield ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 2). Use of Grubbs' I and II generation catalysts exhibited considerable conversion of benzyl alcohol and resulted in respective yields of 47 and 59% of amides isolated by silica-gel column chromatography purification ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 3 and 4).

###### α-Alkylation of *N*,*N*-Dimethylacetamide Using Various Ru-NHC catalysts[a](#t2fn1){ref-type="table-fn"}

![](ao-2017-01152y_0006){#fx2}

  entry   metal catalyst (mol %)        conv. of alcohol (%)   isolated yield of amide **1a** (%)   TON
  ------- ----------------------------- ---------------------- ------------------------------------ -----
  1       catalyst **2a** (1 mol %)     80                     71                                   71
  2       catalyst **2b** (1 mol %)     67                     56                                   56
  3       Grubbs' I (1 mol %)           71                     47                                   47
  4       Grubbs' II **2c** (1 mol %)   81                     59                                   59

Reaction conditions: Catalyst (see Table 2, 1 mol %), benzyl alcohol (1 mmol), *N*,*N*-dimethylacetamide (2 mL), and KO*t*Bu (1.3 mmol) were heated at 140 °C for 16 h.

In contrast to the Grubbs' catalysts, the catalysts **2a** and **2b** were air stable and did not undergo any reactivity changes over a long period of time when exposed to the atmosphere. Next, the same optimized conditions were used for a range of alcohols for the alkylation of amide to get the respective α-alkylated products **1b**--**k** in moderate yield ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The *N*-acetyl derivatives of pyrrolidine, pyridine, and morpholine were also successful with benzyl alcohol in the presence of 1.0 mol % of catalyst **2a**, leading to moderate conversion to give the respective alkylated products **1l**--**n** in 38--48% yields. All products were purified by silica-gel column chromatography and characterized by spectroscopic techniques.

![Ru-NHC Catalyzed α-Alkylation of DMA\
Reaction conditions: Complex **2a** (0.01 mmol), alcohol (1.0 mmol), KO*t*Bu (1.3 mmol), and *N*,*N*-dimethylacetamide (23.0 mmol) were heated at 140 °C in a sealed tube for 16 h.](ao-2017-01152y_0008){#sch2}

The scope of this α-alkylation reaction was extended to 2-oxindole substrate to give the relevant products, which have potential application in drugs and also as scaffolds in many alkaloids. Thus, reaction of 2-oxindole and benzyl alcohol was studied and subjected to the optimized conditions such as catalyst loading, temperature, reaction time, and base ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The reaction was performed in the presence of various concentrations of the Ru-NHC catalyst **2a**, and it was found that the reaction with 1.0 mol % catalyst underwent complete conversion of benzyl alcohol. Lowering the catalyst loading to 0.8, 0.6, and 0.1% led to a decrease in the conversion of benzyl alcohol. This reaction was also screened at various temperatures, revealing that performing the reaction at 140--160 °C led to complete conversion of the alcohols. Upon lowering the temperature from 140 to 80 °C, lower conversion of the benzyl alcohol was observed. Upon subjecting the reaction to optimized catalyst loading and temperature conditions, the reaction was monitored at different time intervals. From these studies, it was observed that the complete conversion of benzyl alcohol was observed after heating at 140 °C for 16 h. When the reaction was conducted under a nitrogen atmosphere in a closed system, it afforded the C3-benzylated 2-oxindole **4a** as the sole product in 94% yield.

![Reaction profile of 2-oxindole with benzyl alcohol.](ao-2017-01152y_0003){#fig2}

Screening the effect of base for this reaction revealed that CsF and Cs~2~CO~3~ were inefficient and led to lower conversion of benzyl alcohol. The use of bases such as K~2~CO~3~ and K~3~PO~4~ results in better conversion of the alcohol, and higher conversion was observed in the case of KO*t*Bu ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). This reaction was also investigated with various concentrations of KO*t*Bu ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}), which revealed that use of 1.3 equiv of KO*t*Bu led to product **4a** in 94% yield. Furthermore, this reaction requires an excess of 2-oxindole to get the product **4a** in better yield. Lowering the 2-oxindole concentration from 2 to 1 equiv led to a decrease in the yield of the product **4a** ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### Effect of KO*t*Bu Concentration on α-Benzylation of Oxindole[a](#t3fn1){ref-type="table-fn"}

  entry   2-oxindole (equiv)   KO*t*Bu (equiv)   catalyst **2a** (mol %)   isolated yield of **4a** (%)
  ------- -------------------- ----------------- ------------------------- ------------------------------
  1       2                    0.2               1                         49
  2       2                    0.4               1                         60
  3       2                    0.6               1                         62
  4       2                    0.8               1                         74
  5       2                    1.3               1                         94
  6       1.5                  1.3               1                         73
  7       1                    1.3               1                         57

Reaction conditions: Benzyl alcohol (1 mmol), 2-oxindole (see table), KO*t*Bu (see table), and 1 mol % catalyst **2a** in toluene were heated in a sealed tube at 140 °C for 16 h.

Several other alcohols were reacted under these optimized conditions. Substituted aromatic alcohols reacted smoothly to give the C3-alkylated 2-oxindole **4a**--**g** in very good yields ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Aliphatic alcohols were also effective for this C3 alkylation to give the corresponding products **4h**--**l** in moderate to good yields, but this required 2 mol % of the Ru-NHC catalyst for better yields. This reaction with estrone and benzyl alcohol, 4-fluorobenzyl alcohol, and trifluorobenzyl alcohol afforded the corresponding alkylated products **4m**--**o** in very good yield.

![Ru-NHC Catalyzed α-Alkylation of 2-Oxindole\
Reaction conditions: alcohol (1 mmol), 2-oxindole (2 mmol), KO*t*Bu (1.3 mmol), and catalyst 2a (1 mol %) in toluene were heated at 140 °C for 16 h.](ao-2017-01152y_0004){#sch3}

We further explored the scope of our method to develop a one pot double functionalization process to synthesize quaternary hydroxyl C3-alkylated 2-oxindole. This will allow rapid access to double functionalized 2-oxindole in one pot. To achieve the one pot C--H alkylation and subsequent aerobic C--H hydroxylation, a set of conditions was established after a series of experiments, which included temperature, time, base concentration, and various catalysts ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Thus, heating the reaction mixture of 2-oxindole, benzyl alcohol, catalyst **2a**, and KO*t*Bu in toluene solution at 50, 80, 100, and 140 °C and further exposing to atmospheric air for 24 h at room temperature afforded the product **5a** in 0, 31, 45, and 69% yield ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entries 1--4), indicating that higher temperature facilitated the higher conversion and higher yield of the product **5a**. Interestingly, this reaction ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entry 4) afforded quaternary hydroxyl C3-benzylated 2-oxindole **5a** (69%) as the major product along with a minor amount (10%) of the C3-alkylated products. Lowering the amount of 2-oxindole (1 mmol) led to a decrease in the yield of product **5a** to 40% ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entry 5). Furthermore, a gradual decrease in the amount KO*t*Bu from 2.3 to 0 equiv decreases the yield of the product 5a ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entries 6--10). It was also observed that decreasing the reaction time led to lowering the yield of product **5a** ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entries 11 and 12). Decrease in yield of the product **5a** was observed on this reaction while using other catalysts **2b**, Grubbs' I and Grubbs' II ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entries 13--15).

###### Optimization for Synthesis of 3-Benzyl-3-hydroxyindolin-2-one at Various Reaction Conditions[a](#t4fn1){ref-type="table-fn"}

![](ao-2017-01152y_0011){#fx3}

  entry                               metal catalyst (1 mol %)   KO*t*Bu (equiv)   temp (°C)   time (h)   isolated yield of **5a** (%)
  ----------------------------------- -------------------------- ----------------- ----------- ---------- ------------------------------
  1                                   catalyst **2a**            2.3               50          24         no reaction
  2                                   catalyst **2a**            2.3               80          24         31
  3                                   catalyst **2a**            2.3               100         24         45
  4                                   catalyst **2a**            2.3               140         24         69
  5[b](#t4fn2){ref-type="table-fn"}   catalyst **2a**            2.3               140         24         40
  6                                   catalyst **2a**            2.0               140         24         58
  7                                   catalyst **2a**            1.9               140         24         49
  8                                   catalyst **2a**            1.6               140         24         37
  9                                   catalyst **2a**            1.0               140         24         10
  10                                  catalyst **2a**            0                 140         24         no reaction
  11                                  catalyst **2a**            1.3               140         16         59
  12                                  catalyst **2a**            1.3               140         8          45
  13                                  catalyst **2b**            1.3               140         24         54
  14                                  Grubbs' I                  1.3               140         24         43
  15                                  Grubbs' II **2c**          1.3               140         24         55

Reaction conditions: alcohol (1 mmol), 2-oxindole (2 mmol), KO*t*Bu (1.3 mmol), and 1 mol % catalyst **2a** in toluene were heated at 140 °C for 16 h followed by addition of 1 mmol of KO*t*Bu and kept at rt for 24 h.

2-Oxindole (1 mmol) used.

To expand the scope of this approach, a range of aromatic alcohols were reacted with 2-oxindole ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Methyl substitution on para/meta to benzyl alcohol gave similar yields ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}) of **5b**/**c** (50/45%). In the case of 2-methoxybenzyl alcohol, a moderate yield of the product **5d** (55%) was observed. Methoxy substitution on the meta position gave **5e** in poor yield (25%). Interestingly, a bromo substituent on the meta position afforded **5f** in 53% yield as observed in the case of ortho/para substituents. Biphenyl methanol gave **5g** in 42% yield. Aliphatic alcohols such as butanol, hexanol, octanol, and iso-amyl alcohol were also reacted to give the respective quaternary hydroxy C3-alkylated products **5h**--**j** in 35--48% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Next, the effect of N-substitution on 2-oxindole was studied. As a model substrate, N-benzylated 2-oxindole was prepared and reacted with a variety of aromatic and aliphatic alcohols. All aliphatic alcohols gave the corresponding product and did not display any improvement in the yield of the products **5k**--**n** (33--48%, [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}), as observed in the case of 2-oxindole. Reaction with benzyl alcohol gave **5o** in 65% yield. A slight decrease in yield was observed for aromatic alcohols with ortho/para methoxy/methyl substituents to afford quaternary C3-hydroxy products **5p**--**t** in 40--57% yields ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). A considerable decrease in yield of quaternary C3-hydroxy product **5u** was observed in the case of meta methylated benzyl alcohol. This reaction was also successful with biphenyl methanol to give the highly aromatic ring centered quaternary hydroxylated product **5v** (45%). Interestingly, this reaction was functional group tolerant, upon reaction with 3-bromobenzyl alcohol, to afford the bromo-functionalized product **5w** in 50% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Interestingly, these domino reactions were also successful with substituted 2-oxindole. Upon reaction of 6-chloro-2-oxindole with benzyl alcohol, 4-methylbenzyl alcohol, biphenyl methanol, 1-butanol, and 1-octanol in the presence of Ru-NHC (**2a**) catalyst afforded the respective products **5a′**--**e′** in moderate yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Ru-NHC Catalyzed Domino C--H Alkylation and C--H Hydroxylation of 2-Oxindole\
Reaction conditions: Alcohol (1 mmol), 2-oxindole (2 mmol), KO*t*Bu (1.3 mmol), and 1 mol % catalyst **2a** in toluene were heated at 140 °C for 16 h followed by addition of 1 mmol of KO*t*Bu and kept at rt for 24 h.](ao-2017-01152y_0014){#sch4}

The scope of this domino reaction was also attempted with 1-tetralone to get α-hydroxy-1-tetralone **7** ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). Upon heating the toluene solution containing benzyl alcohol, 1-tetralone, KO*t*Bu, and 2 mol % of the Ru-NHC catalyst for 24 h, followed by exposure to air for 24 h, silica-gel column purification afforded the respective product **7a** in 69% yield. Substituted benzyl alcohols such as 2/3/4-methylbenzyl alcohol, 2/3/4-methoxybenzyl alcohol, biphenyl methanol, and 3-bromobenzyl alcohol also successfully afforded the appropriate substituted hydroxy functionalized 1-tetralone **7b**--**i** in moderate yield. This approach was also successfully applied to one of the natural products, estrone, to get the D-ring functionalization. Estrone was subjected to C--H alkylation using benzyl alcohol and 4-fluorobenzyl alcohol, and subsequent aerial oxidation under experimental conditions afforded the respective quaternary hydroxyl functionalized products **7j** and **7k** in 38 and 32% yield ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).

![HRMS spectra for the crude reaction performed in a liquid N~2~ cooling bath.](ao-2017-01152y_0013){#fig3}

![Synthesis of β-Hydroxy-1-tetralone\
Reaction conditions: alcohol (1 mmol), ketone (2 mmol), KO*t*Bu (1.3 mmol), and 1 mol % catalyst **2a** in toluene were heated at 140 °C for 16 h followed by addition of 1 mmol of KO*t*Bu and kept at rt for 24 h.](ao-2017-01152y_0009){#sch5}

To demonstrate the synthetic application of this method, we envisioned the formal synthesis of Donaxaridine alkaloid. Therefore, domino C--H alkylation and C--H hydroxylation were directed for the synthesis of Donaxaridine, a potential therapeutic natural product containing the quaternary hydroxyl C3-substituted-2-oxindole scaffold. A toluene reaction mixture containing 2-oxindole, 2-benzyloxy-1-ethanol, KO*t*Bu, and 2.0 mol % of the Ru-NHC catalyst was heated at 140 °C for 24 h and subsequent exposure to air for base-mediated aerobic C--H hydroxylation led to the quaternary hydroxyl product **9a** in 60% yield ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Deprotection of the *O*-benzyl group under hydrogenation catalyzed by 5% Pd-C afforded the dihydroxy functionalized product **10** in 90% yield. Selective *O-*tosylation of the primary alcohol, followed by the reaction with 6M methylamine in ethanol afforded the Donaxaridine **11** in 75% yield ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}).

![Formal Synthesis of Donaxaridine](ao-2017-01152y_0010){#sch6}

On the basis of previous observation,^[@ref10],[@ref12],[@ref13]^ the possible mechanism for the formation of the quaternary hydroxyl C3-alkylated 2-oxindole (**H**) is shown in [Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}. Initially, the alcohol (**A**) forms the aldehyde via Ru-catalyzed dehydrogenation, which undergoes base-mediated condensation with 2-oxindole to give the intermediate **C**. The unsaturated intermediate **C** is hydrogenated in the presence of Ru-catalyst to give the C3-alkyl-2-oxindole intermediate **D**. Because the reaction was performed under inert conditions, exclusive formation of the intermediate **D** ruled out the water addition across the Ru--alkoxy intermediate **I**.^[@ref12]^ Allowing the reaction to mix under air generates the intermediates **F** and **G** via C--H peroxidation and peroxide cleavage by enolate^[@ref13]^ to afford the product **H**. The formation of the intermediate **G** was confirmed by freezing the crude reaction mixture using liquid N~2~ followed by immediate injection into a HRMS instrument, which observed the mass value of 294.0537, which corresponds to the intermediate **G** as a potassium adduct. This clearly evidenced that the C--H hydroxylation is facilitated by atmospheric oxygen.

![Possible Mechanism for Domino C--H Alkylation and Hydroxylation](ao-2017-01152y_0001){#sch7}

3. Conclusions {#sec3}
==============

In summary, a well-defined air stable Ru-NHC catalyzed domino C--H alkylation reaction of amides using alcohols was developed. These reactions proceeded via dehydrogenation--condensation--hydrogenation steps in a domino manner. A new approach for the tandem C--H alkylation followed by an aerobic base-mediated C--H hydroxylation was achieved with a complete atom economical approach. Swapping the reaction conditions between that under air or inert, the reaction product can be switched to C--H alkylation or C--H alkylation--hydroxylation. For the first time, using the borrowing hydrogen approach, a key intermediate for the Donaxaridine alkaloid was synthesized in good yield directly from 2-oxindole.

4. Experimental Section {#sec4}
=======================

All experiments with Ru-catalyst were carried out under an atmosphere of nitrogen. All alcohols and amides were purchased from Sigma-Aldrich or Alfa-Aesar and stored over molecular sieves. Deuterated solvents were used as received. All solvents used were dry grade and stored over 4 Å molecular sieves. Column chromatographic separations were performed over 100--200 silica gel. Visualization of thin-layer chromatography was accomplished with UV light and iodine. Ru-NHC **2a** and **2b** complexes were prepared according to literature procedures.^[@ref14]1^H and ^13^C NMR spectra were recorded using Bruker and Jeol 400 and 100 MHz spectrometers. Abbreviations used in the NMR follow-up experiments: b, broad; s, singlet; d, doublet; t, triplet; q, quartet; td, doublet of triplet; dd, double doublet; m, multiplet. High resolution mass spectra were obtained with a Waters-synapt G2 using electrospray ionization (ESI). Fourier-transform infrared spectra were obtained with a Bruker Alpha-E Fourier-transform infrared spectrometer.

4.1. General Experimental Procedure for the α-Alkylation of Unactivated Amides (Method A) {#sec4.1}
-----------------------------------------------------------------------------------------

Ru-NHC complex (0.01 mmol), KO*t*Bu (1.3 mmol), alcohol (1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were added to an oven-dried 20 mL resealable pressure tube (equipped with rubber septum) under a N~2~ atmosphere using a N~2~ balloon. Then, the tube was purged with N~2~ and the septum was quickly removed, then the tube was sealed with a cap using a crimper. The reaction mixture was stirred at 140 °C for 16 h. After cooling to room temperature, mesitylene (1.0 mmol) was added, and the products were analyzed by GC. The reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (3 × 20 mL). The entire ethyl acetate layer was combined, washed with brine (30 mL), and then dried over Na~2~SO~4~. After concentration under reduced pressure, the residue was purified by 100--200 mesh silica-gel column chromatography. (In the case of aliphatic alcohols, 0.02 mmol of Ru-NHC catalyst was used and heated for 24 h. In the case of cyclic amides, the reaction was heated for 24 h.)

### 4.1.1. *N*,*N*-Dimethyl-3-phenylpropanamide (**1a**)^[@ref12]^ {#sec4.1.1}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1a** (125 mg, 71%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.34--7.21 (m, 5H), 3.02--2.96 (m, 8H), 2.64 (t, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.33, 141.62, 128.58, 128.54, 128.45, 127.16, 126.21, 37.28, 35.56, 35.42, 31.51. IR (neat) 1642 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~11~H~15~NO (M + H)^+^: 178.1232, found: 178.1235.

### 4.1.2. *N*,*N*-Dimethyl-3-*o*-tolylpropanamide (**1b**)^[@ref12]^ {#sec4.1.2}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 2-methylbenzyl alcohol (122 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1b** (140 mg, 73%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.17--7.09 (m, 4H), 2.98--2.93 (m, 8H), 2.56 (t, 2H), 2.33 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.48, 139.67, 136.1, 130.39, 128.89, 126.39, 126.22, 37.27, 35.57, 34.04, 28.82, 19.41. IR (neat) 1641.9 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO (M + H)^+^: 192.1388, found: 192.1391.

### 4.1.3. *N*,*N*-Dimethyl-3-*m*-tolylpropanamide (**1c**)^[@ref12]^ {#sec4.1.3}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 3-methylbenzyl alcohol (122 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1c** (135 mg, 71%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.18 (t, 1H), 7.03--7.01 (m, 3H), 2.95--2.90 (m, 8H), 2.60 (t, 2H), 2.33 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.43, 141.57, 138.17, 129.36, 128.5, 126.96, 125.52, 37.31, 35.52, 35.57, 31.45, 21.51. IR (neat) 1642.7 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO (M + H)^+^: 192.1388, found: 192.1390.

### 4.1.4. *N*,*N*-Dimethyl-3-*p*-tolylpropanamide (**1d**)^[@ref12]^ {#sec4.1.4}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 4-methylbenzyl alcohol (122 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1d** (132 mg, 69%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.13--7.08 (m, 4H), 2.95--2.90 (m, 8H), 2.59 (t, 2H), 2.32 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.42, 138.52, 135.69, 129.25, 128.41, 37.29, 35.61, 35.55, 31.06, 21.12. IR (neat) 1641.04 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO (M + H)^+^: 192.1388, found: 192.1393.

### 4.1.5. 3-(2-Methoxyphenyl)-*N*,*N*-dimethylpropanamide (**1e**)^[@ref2]^ {#sec4.1.5}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 2-methoxybenzyl alcohol (138 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1e** (150 mg, 72%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.21--7.16 (m, 2H), 6.89--6.83 (m, 2H), 3.82 (s, 3H), 2.95--2.94 (m, 8H), 2.59 (t, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 173.04, 157.59, 130.3, 127.58, 120.63, 114.32, 110.29, 55.30, 37.28, 35.49, 33.84, 26.80. IR (neat) 1643.9 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO~2~ (M + H)^+^: 208.1337, found: 208.1340.

### 4.1.6. 3-(3-Methoxyphenyl)-*N*,*N*-dimethylpropanamide (**1f**)^[@ref12]^ {#sec4.1.6}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 3-methoxybenzyl alcohol (138 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1f** (145 mg, 70%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.22--7.18 (m, 1H), 6.82--6.73 (m, 3H), 3.79 (s, 3H), 2.95--2.93 (m, 8H), 2.60 (t, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.30, 159.81, 143.26, 129.57, 120.89, 114.30, 111.50, 55.29, 37.30, 35.58, 35.35, 31.55. IR (neat) 1640.4 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO~2~ (M + H)^+^: 208.1337, found: 208.1344.

### 4.1.7. 3-(4-Methoxyphenyl)-*N*,*N*-dimethylpropanamide (**1g**)^[@ref12]^ {#sec4.1.7}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 4-methoxybenzyl alcohol (138 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1g** (133 mg, 64%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.13 (d, *J* = 8 Hz, 2H), 6.82 (d, *J* = 8 Hz, 2H), 3.78 (s, 3H), 2.94--2.92 (m, 8H), 2.58 (t, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 172.54, 158.08, 133.61, 129.48, 113.98, 55.38, 37.34, 35.69, 35.58, 30.62. IR (neat) 1640.85 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~17~NO~2~ (M + H)^+^: 208.1337, found: 208.1339.

### 4.1.8. *N*,*N*-Dimethylhexanamide (**1h**)^[@ref12]^ {#sec4.1.8}

Complex **2a** (12.10 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), butanol (74 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1h** (59 mg, 41%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 2.99 (s, 3H), 2.93 (s, 3H), 2.29 (t, *J* = 8 Hz, 2H), 1.62 (quintet, *J* = 8 Hz, 2H), 1.30--1.33 (m, 4H), 0.89 (m, 3H). ^13^C NMR (100 MHz, CDCl~3~) 173.55, 37.46, 35.51, 33.51, 31.81, 25.01, 22.62, 14.1. IR (neat) 1643 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~8~H~17~NO (M + H)^+^: 144.1388, found: 144.1390.

### 4.1.9. *N*,*N*-Dimethyloctanamide (**1i**)^[@ref12]^ {#sec4.1.9}

Complex **2a** (12.10 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), hexanol (102 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1i** (71 mg, 42%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 2.99 (s, 3H), 2.93 (s, 3H), 2.29 (t, *J* = 8 Hz, 2H), 1.61 (quintet, *J* = 8 Hz, 2H), 1.30--1.27 (m, 8H), 0.86 (m, 3H). ^13^C NMR (100 MHz, CDCl~3~) 173.44, 37.44, 35.49, 33.57, 31.87, 29.62, 29.25, 22.76, 14.21. IR (neat) 1642.8 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~10~H~21~NO (M + H)^+^: 172.1701, found: 172.1701.

### 4.1.10. *N*,*N*-Dimethyldecanamide (**1j**)^[@ref12]^ {#sec4.1.10}

Complex **2a** (12.10 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), octanol (130 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1j** (100.5 mg, 50%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 2.99 (s, 3H), 2.92 (s, 3H), 2.28 (t, *J* = 8 Hz, 2H), 1.60 (quintet, *J* = 8 Hz, 2H), 1.28--1.24 (m, 12H), 0.86 (m, 3H). ^13^C NMR (100 MHz, CDCl~3~) 173.48, 37.43, 33.55, 31.99, 29.64, 29.6, 29.58, 29.4, 25.33, 22.77, 14.19. IR (neat) 1645.6 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~25~NO (M + H)^+^: 200.2014, found: 200.2016.

### 4.1.11. *N*,*N*-Dimethyl-5-methylhexanamide (**1k**)^[@ref12]^ {#sec4.1.11}

Complex **2a** (12.10 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), iso-amyl alcohol (88 mg, 1 mmol), and *N*,*N*-dimethylacetamide (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the amide **1k** (65 mg, 41%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 3.00 (s, 3H), 2.94 (s, 3H), 2.28 (t, *J* = 8 Hz, 2H), 1.66--1.56 (m, 5H), 1.21 (m, 2H), 0.88 (d, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 173.45, 38.88, 37.43, 35.49, 33.77, 28.03, 23.18, 22.67. IR (neat) 1644.8 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~9~H~19~NO (M + H)^+^: 158.1545, found: 158.1548.

### 4.1.12. 3-Phenyl-1-(pyrrolidin-1-yl)propan-1-one (**1l**)^[@ref12]^ {#sec4.1.12}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1 mmol), and *N-*acetylpyrrolidine (226 mg, 2 mmol) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the cyclic amide **1l** (78 mg, 38%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.28--7.21 (m, 5H), 3.46 (t, 2H), 3.28 (t, 2H), 2.98 (t, *J* = 8 Hz, 2H), 2.56 (t, *J* = 8.0 Hz, 2H), 1.89--1.80 (m, 4H). ^13^C NMR (100 MHz, CDCl~3~) δ 170.97, 141.64, 128.88, 128.57, 127.96, 126.19, 46.71, 45.79, 36.89, 31.36, 26.18, 24.51. IR (neat) 1641.8 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~13~H~17~NO (M + H)^+^: 204.1388, found: 204.1389.

### 4.1.13. 3-Phenyl-1-(piperidin-1-yl)propan-1-one (**1m**)^[@ref12]^ {#sec4.1.13}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1 mmol), and *N-*acetylpiperidine (254 mg, 2 mmol) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the cyclic amide **1m** (105 mg, 48%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.18--7.05 (m, 5H), 3.43 (t, 2H), 3.20 (t, 2H), 2.84 (t, *J* = 8 Hz, 2H), 2.49 (t, *J* = 8.0 Hz, 2H), 1.31--1.48 (m, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 170.58, 141.63, 128.6, 128.58, 126.93, 126.22, 46.77, 42.87, 35.33, 31.77, 26.54, 25.69, 24.76, 24.68. IR (neat) 1633.9 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~14~H~19~NO (M + H)^+^: 218.1545, found: 218.1547.

### 4.1.14. 1-Morpholino-3-phenylpropan-1-one (**1n**)^[@ref12]^ {#sec4.1.14}

Complex **2a** (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1 mmol), and *N-*acetyl morpholine (258 mg, 2 mmol) were allowed to react in a 20 mL resealable pressure tube according to method A to afford the cyclic amide **1n** (88 mg, 40%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.16--7.05 (m, 5H), 3.47 (s, 4H), 3.35 (t, *J* = 4 Hz, 2H), 3.2 (t, *J* = 4 Hz, 2H), 2.82 (t, *J* = 8 Hz, 2H), 2.46 (t, *J* = 8 Hz, 2H). ^13^C NMR (100 Hz, CDCl~3~) δ 171.05, 141.16, 128.68, 128.59, 127.21, 126.41, 66.98, 66.59, 46.1, 42.07, 34.94, 31.61. IR (neat) 1639 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~13~H~17~NO~2~ (M + H)^+^: 220.1337, found: 220.1343.

4.2. General Experimental Procedure for C3 Alkylation of 2-Oxindole and N-Protected 2-Oxindole (Method B) {#sec4.2}
---------------------------------------------------------------------------------------------------------

Ru-NHC complex (0.01 mmol), KO*t*Bu (1.3 mmol), alcohol (1 mmol), and 2-oxindole (2 mmol) were added to an oven-dried 20 mL resealable pressure tube (equipped with rubber septum) under a N~2~ atmosphere using a balloon. Then, the tube was purged with N~2~, and the septum was quickly removed and the tube was sealed with a cap using a crimper. The reaction mixture was stirred at 140 °C for 16 h. After cooling to room temperature, the reaction mixture was passed through a celite bed. After concentration under reduced pressure, the residue was purified by 100--200 mesh silica-gel column chromatography to afford the pure product. (In the case of aliphatic alcohols, 0.02 mmol of Ru-NHC catalyst was used and heated for 24 h.)

### 4.2.1. 3-Benzylindolin-2-one (**4a**)^[@cit8d]^ {#sec4.2.1}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-benzylindolin-2-one (209 mg, 94%) as a yellow solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.80 (bs, 1H), 7.29--7.27 (m, 1H), 7.25--7.22 (m, 2H), 7.20--7.15 (m, 3H), 6.92--6.89 (dt, *J* = 4 Hz, 1H), 6.86 (d, *J* = 8 Hz, 1H), 6.75 (d, *J* = 8 Hz, 1H), 3.76 (dd, *J* = 9.2, 4.6 Hz, 1H), 3.51 (dd, *J* = 13.7, 4.6 Hz, 1H), 2.95 (dd, *J* = 13.7, 9.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.77, 141.50, 137.88, 129.52, 129.05, 128.43, 128.05, 126.77, 124.94, 122.11, 109.81, 47.63, 36.71.

IR (neat) 1705.75 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~15~H~13~NO (M + H)^+^: 224.1075, found: 224.1085.

### 4.2.2. 3-(4-Methylbenzyl)indolin-2-one (**4b**)^[@cit8d]^ {#sec4.2.2}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 4-methyl benzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-(4-methylbenzyl)indolin-2-one (201 mg, 85%) as a yellow solid.

^1^H NMR (400 MHz, CDCl~3~) δ 9.10 (s, 1H), 7.16 (dd, *J* = 12, 4 Hz, 1H), 7.11--7.03 (m, 4H), 6.94--6.83 (m, 2H), 6.77 (d, *J* = 8 Hz, 1H), 3.74 (dd, *J* = 8, 4 Hz, 1H), 3.47 (dd, *J* = 12, 4 Hz, 1H), 2.91 (dd, *J* = 12, 8 Hz, 1H), 2.31 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.01, 141.62, 136.27, 134.81, 129.61, 29.02, 128.01, 124.96, 122.08, 109.88, 47.77, 36.33, 21.18. IR (neat) 1703.72 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO (M + H)^+^: 238.1232, found: 238.1241.

### 4.2.3. 3-(2-Methylbenzyl)indolin-2-one (**4c**)^[@cit8d]^ {#sec4.2.3}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 3-methyl benzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-(2-methylbenzyl)indolin-2-one (220 mg, 93%) as a yellow crystalline solid. ^1^H NMR (400 MHz, CDCl~3~) δ 9.34 (bs, 1H), 7.36--7.28 (m, 1H), 7.20--7.17 (m, 4H), 6.95--6.92 (m, 1H), 6.85 (t, *J* = 8 Hz, 1H), 6.54 (d, *J* = 8 Hz, 1H), 3.72 (dd, *J* = 10.9, 4.5 Hz, 1H), 3.52 (dd, *J* = 13, 4.0 Hz, 1H), 2.81 (dd, *J* = 12, 8 Hz, 1H), 2.31 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.34, 141.58, 136.80, 136.67, 130.62, 130.16, 129.30, 128.04, 126.98, 125.97, 125.10, 122.02, 110.17, 46.41, 34.40, 19.90.

IR (neat) 1704.66 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO (M + H)^+^: 238.1232, found: 238.1245.

### 4.2.4. 3-(3-Methylbenzyl)indolin-2-one (**4d**)^[@cit8d]^ {#sec4.2.4}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 3-methyl benzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-(3-methylbenzyl)indolin-2-one (196 mg, 83%) as a yellow solid. ^1^H NMR (400 MHz, CDCl~3~) δ 9.68 (bs, 1H), 7.21--7.16 (t, *J* = 8 Hz, 2H), 7.07--7.01 (m, 3H), 6.94--6.92 (t, *J* = 8 Hz, 2H), 6.76--6.74 (d, *J* = 8 Hz, 1H), 3.77 (dd, *J* = 9.5, 4.4 Hz, 1H), 3.51 (dd, *J* = 13.7, 4.0 Hz, 1H), 2.88 (dd, *J* = 13.6, 9.7 Hz, 1H), 2.01 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.57, 141.98, 138.05, 131.17, 129.87, 129.44, 128.36, 128.06, 127.54, 126.55, 124.93, 121.98, 111.00, 47.78, 36.73, 21.51. IR (neat) 1714.56 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO (M + H)^+^: 238.1232, found: 238.1242.

### 4.2.5. 3-(3-Methoxybenzyl)indolin-2-one (**4e**) {#sec4.2.5}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), 3-methoxybenzyl alcohol (138 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-(3-methoxybenzyl)indolin-2-one (172 mg, 68%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.93 (bs, 1H), 7.17 (t, *J* = 8 Hz, 2H), 6.91 (td, *J* = 7.6, 1.0 Hz, 1H), 6.66 (d, *J* = 8 Hz, 1H), 6.80--6.73 (m, 4H), 3.75 (dd, *J* = 9.3, 4.5 Hz, 1H), 3.72 (s, 3H), 3.48 (dd, *J* = 13.7, 4.5 Hz, 1H), 2.91 (dd, *J* = 13.7, 9.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.83, 159.64, 141.59, 139.51, 129.43, 129.12, 128.10, 125.00, 122.16, 121.95, 114.85, 112.56, 109.89, 55.25, 47.60, 36.80. IR (neat) 1707.80 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO~2~ (M + H)^+^: 254.1181, found: 254.1188.

### 4.2.6. 3-(3-Bromobenzyl)indolin-2-one (**4f**) {#sec4.2.6}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), biphenyl-4-methanol (185 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford **3**-(\[1,1′-biphenyl\]-4-ylmethyl)indolin-2-one (240 mg, 80%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.76 (s, 1H), 7.37--7.32 (m, 2H), 7.17 (tt, *J* = 6.8, 3.0 Hz, 1H), 7.04--7.00 (m, 2H), 6.93 (tt, *J* = 8.4, 4.1 Hz, 1H), 6.84 (dd, *J* = 7.6, 2.9 Hz, 2H), 3.73 (dd, *J* = 8.5, 4.6 Hz, 1H), 3.39 (dd, *J* = 13.8, 4.7 Hz, 1H), 2.98 (dd, *J* = 8, 4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.49, 141.55, 136.65, 131.46, 131.26, 128.52, 128.26, 124.73, 122.26, 120.72, 109.98, 47.37, 35.95. IR (neat) 1707.92 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~15~H~12~ BrNO (M + H)^+^: 302.0180, found: 302.0189.

### 4.2.7. 3-(\[1,1′-Biphenyl\]-4-ylmethyl)indolin-2-one (**4g**) {#sec4.2.7}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), biphenyl-4-methanol (184 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-(\[1,1′-biphenyl\]-4-ylmethyl)indolin-2-one (252 mg, 84%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.84 (s, 1H), 7.63--7.58 (m, 2H), 7.54--7.50 (m, 2H), 7.48--7.43 (m, 2H), 7.40--7.32 (m, 1H), 7.28 (d, *J* = 8.0 Hz, 2H), 7.23--7.18 (m, 1H), 6.96 (td, *J* = 7.5, 0.9 Hz, 1H), 6.89 (dd, *J* = 11.0, 7.6 Hz, 2H), 3.82 (dd, *J* = 9.1, 4.5 Hz, 1H), 3.56 (dd, *J* = 13.7, 4.6 Hz, 1H), 3.03 (dd, *J* = 13.7, 9.1 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.78, 141.57, 140.80, 139.52, 136.97, 129.94, 129.08, 128.84, 128.12, 127.20, 127.07, 127.03, 124.94, 122.18, 109.91, 47.60, 36.34. IR (neat) 1706.11 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~21~H~17~NO (M + H)^+^: 300.1388, found: 300.1394.

### 4.2.8. 3-Isopentylindolin-2-one (**4h**) {#sec4.2.8}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), amyl alcohol (88 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-isopentylindolin-2-one (98 mg, 48%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 9.58 (bs, 1H), 7.24--7.19 (m, 2H), 7.04--7.00 (m, 1H), 6.94 (d, *J* = 7.6 Hz, 1H), 3.47 (t, *J* = 8 Hz, 1H), 2.05--1.92 (m, 2H), 1.58--1.52 (m, 1H), 1.35--1.16 (m, 2H), 0.87 (d *J* = 8 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 181.44, 141.97, 130.02, 127.85, 124.11, 122.29, 110.01, 46.43, 34.71, 28.50, 28.21, 22.51. IR (neat) 1701.71 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~13~H~17~NO (M + H)^+^: 204.1388, found: 204.1391.

### 4.2.9. 3-Hexylindolin-2-one (**4i**) {#sec4.2.9}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), 1-hexanol (102 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to 3-hexylindolin-2-one (174 mg, 80%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.97 (s, 1H), 7.24--7.18 (m, 2H), 7.01 (dd, *J* = 11.0, 4.1 Hz, 1H), 6.91 (d, *J* = 7.6 Hz, 1H), 3.47 (t, *J* = 6.0 Hz, 1H), 2.07--1.87 (m, 2H), 1.44--1.25 (m, 8H), 0.85 (t, *J* = 6.9 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 181.06, 141.78, 130.03, 127.83, 124.17, 122.27, 109.85, 46.27, 31.64, 30.62, 29.35, 25.82, 22.66, 14.11. IR (neat) 1701.48, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~14~H~19~NO (M + H)^+^: 218.1545, found: 218.1552.

### 4.2.10. 3-Octylindolin-2-one (**4j**) {#sec4.2.10}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), 1-octanol (130 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to afford 3-octylindolin-2-one (183 mg, 75%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 9.90 (s, 1H), 7.23 (dd, *J* = 13.7, 7.4 Hz, 2H), 7.07--7.01 (m, 1H), 6.98 (d, *J* = 7.7 Hz, 1H), 3.50 (t, *J* = 6.0 Hz, 1H), 2.08--1.90 (m, 2H), 1.52--1.20 (m, 12H), 0.89 (t, *J* = 6.9 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 181.66, 142.07, 130.07, 127.83, 124.07, 122.21, 110.07, 46.41, 31.91, 30.62, 29.72, 29.42, 29.33, 25.88, 22.72, 14.18. IR (neat) 1715.57 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~23~NO (M + H)^+^: 246.1858, found: 246.1861.

### 4.2.11. 1-Benzyl-3-butylindolin-2-one (**4k**) {#sec4.2.11}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), iso-amyl alcohol (88 mg, 1 mmol), *N*-benzyl oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to 1-benzyl-3-butylindolin-2-one (94 mg, 34%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.35--7.29 (m, 5H), 7.29--7.27 (m, 1H), 7.20--7.14 (m, 1H), 7.03 (td, *J* = 8, 0.9 Hz, 1H), 6.73 (d, *J* = 7.7 Hz, 1H), 4.99 (d, *J* = 16 Hz, 1H), 4.87 (d, *J* = 16 Hz, 1H), 3.55 (t, *J* = 6.0 Hz, 1H), 2.06--2.00 (m, 2H), 1.47--1.24 (m, 5H), 0.90 (t, *J* = 8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.20, 143.59, 136.15, 129.41, 128.82, 127.77, 127.63, 127.39, 124.00, 122.36, 109.03, 45.66, 43.74, 30.64, 28.09, 22.82, 13.98. IR (neat) 1703.95, 3031.76 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~19~H~22~NO (M + H)^+^: 280.1701, found: 280.1707.

### 4.2.12. 1-Benzyl-3-isopentylindolin-2-one (**4l**) {#sec4.2.12}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (146 mg, 1.3 mmol), *iso*-amyl alcohol (88 mg, 1 mmol), *N*-benzyl oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method B to 1-benzyl-3-isopentylindolin-2-one (128 mg, 44%) as a colorless liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.29--7.27 (m, 4H), 7.23--7.21 (m, 2H), 7.14--7.10 (m, 1H), 6.98 (dd, *J* = 7.6, 6.6 Hz, 1H), 6.68 (d, *J* = 8 Hz, 1H), 4.95 (d, *J* = 16 Hz, 1H), 4.82 (d, *J* = 16 Hz, 1H), 3.50 (t, *J* = 4 Hz, 1H), 2.05--1.94 (m, 2H), 1.56--1.49 (m, 1H), 1.28--1.14 (m, 2H), 0.85 (d, *J* = 8 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.13, 143.58, 136.13, 129.35, 128.78, 127.76, 127.61, 127.38, 123.95, 122.35, 109.00, 45.72, 43.70, 34.79, 28.76, 28.19, 22.52. IR (neat) 1704.99 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~20~H~23~NO (M + H)^+^: 294.1858, found: 294.1873.

### 4.2.13. (8*R*,9*S*,13*S*,14*S*)-16-Benzyl-3-methoxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17*H*-cyclopenta\[*a*\]phenanthren-17-one (**4m**)^[@cit4a]^ {#sec4.2.13}

Ru-NHC complex (1.5 mg, 0.0025 mmol), KO*t*Bu (36 mg, 0.32 mmol), benzyl alcohol (27 mg, 0.25 mmol), and estron 3-methyl ether (72 mg, 0.25 mmol) were allowed to react in a 20 mL resealable pressure tube according to method B to afford the product **4m** (85 mg, 92%) as a white crystalline solid with a mixture of diastereoisomers based on ^1^H NMR spectra. Spectral data for major diastereoisomer: ^1^H NMR (400 MHz, CDCl~3~) δ 7.58 (d, *J* = 7.3 Hz, 1H), 7.43 (d, *J* = 7.7 Hz, 1H), 7.31 (t, *J* = 7.3 Hz, 3H), 6.77--6.70 (m, 2H), 6.64 (d, *J* = 2.7 Hz, 2H), 3.78 (s, 3H), 3.24 (dd, *J* = 13.6, 4.1 Hz, 1H), 3.04--2.84 (m, 6H), 2.70 (dd, *J* = 13.6, 9.8 Hz, 1H), 2.15--2.03 (m, 3H), 1.70--1.53 (m, 5H), 0.73 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 157.62, 139.90, 137.74, 136.04, 133.21, 132.06, 130.35, 129.03, 128.71, 128.44, 126.29, 113.89, 111.56, 55.22, 51.37, 49.00, 48.58, 46.42, 44.13, 37.86, 37.62, 29.66, 27.94, 26.76, 13.65. IR (neat) 1732.96 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~26~H~30~O~2~ (M + H)^+^: 375.2324, found: 375.2326.

### 4.2.14. (8*R*,9*S*,13*S*,14*S*)-16-(4-Fluorobenzyl)-3-methoxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17*H*-cyclopenta\[*a*\]phenanthren-17-one (**4n**) {#sec4.2.14}

Ru-NHC complex (1.5 mg, 0.0025 mmol), KO*t*Bu (36 mg, 0.32 mmol), 4-fluorobenzyl alcohol (32 mg, 0.25 mmol), and estron 3-methyl ether (71 mg, 0.25 mmol) were allowed to react in a 20 mL resealable pressure tube according to method B to afford the product **4n** (77 mg, 80%) as a white crystalline solid with a mixture of diastereoisomers based on ^1^H NMR spectra. Spectral data for major diastereoisomer: ^1^H NMR (400 MHz, CDCl~3~) δ 7.22--7.18 (m, 2H), 7.04--7.01 (m, 2H), 6.77 (d, *J* = 2.8 Hz, 1H), 6.70 (d, *J* = 2.6 Hz, 2H), 3.83 (s, 3H), 3.23 (dd, *J* = 13.8, 4.2 Hz, 1H), 2.99--2.89 (m, 4H), 2.77 (dd, *J* = 13.8, 9.4 Hz, 1H), 2.50--2.40 (m, 2H), 2.03--2.00 (m, 3H), 1.57 (d, *J* = 9.2 Hz, 3H), 0.76 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 157.65, 137.73, 135.81, 135.51, 132.02, 130.47 (t, *J* = 7.8 Hz), 126.32, 115.34, 115.13, 113.93, 111.62, 55.23, 51.39, 49.01, 48.58, 44.16, 37.87, 36.63, 32.03, 29.69, 27.81, 26.81, 25.92, 13.62. IR (neat) 1733.73 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~26~H~29~FO~2~ (M + H)^+^: 393.2230, found: 393.2232.

### 4.2.15. (8*R*,9*S*,13*S*,14*S*)-3-Methoxy-13-methyl-16-(4-(trifluoromethyl)benzyl)-6,7,8,9,11,12,13,14,15,16-decahydro-17*H*-cyclopenta\[*a*\]phenanthren-17-one (**4o**) {#sec4.2.15}

Ru-NHC complex (1.5 mg, 0.0025 mmol), KO*t*Bu (36 mg, 0.32 mmol), 4-trifluorobenzyl alcohol (44 mg, 0.25 mmol), and estron 3-methyl ether (71 mg, 0.25 mmol) were allowed to react in a 20 mL resealable pressure tube according to method B to afford the product **4o** (92 mg, 88%) as a white crystalline solid with a mixture of diastereoisomers based on ^1^H NMR spectra. Spectral data for major diastereoisomer: ^1^H NMR (400 MHz, CDCl~3~) δ 7.56 (s, 2H), 7.32 (s, 2H), 7.19 (s, 1H), 6.72 (d, *J* = 2.1 Hz, 1H), 6.65 (s, 1H), 3.78 (s, 3H), 3.29 (dd, *J* = 13.7, 4.1 Hz, 1H), 2.88 (dd, *J* = 9.9, 4.7 Hz, 4H), 2.48--2.35 (m, 3H), 2.02--1.91 (m, 3H), 1.59--1.34 (m, 6H), 0.76 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 157.69, 144.16, 137.73, 131.97, 129.35, 126.32, 125.86--124.98 (m), 113.95, 111.64, 55.23, 51.03, 49.01, 48.61, 44.17, 37.88, 32.02, 29.68, 28.00, 26.85, 25.91, 13.82. IR (neat) 1733.33 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~27~H~29~F~3~O~2~ (M + H)^+^: 443.2198, found: 443.2206.

4.3. Experimental Procedure for C--H Alkylation and Aerobic C--H Hydroxylation of 2-Oxindole, α-Tetralone, and N-Protected 2-Oxindole (Method C) {#sec4.3}
------------------------------------------------------------------------------------------------------------------------------------------------

Ru-NHC (0.02 mmol), KO*t*Bu (1.3 mmol), alcohol (1.0 mmol), and 2-oxindole or α-tetralone or N-protected 2-oxindole (2.0 mmol) were added to a 20 mL glass tube under a N~2~ atmosphere. Then, the tube was purged with N~2~ and sealed with a cap using a crimper. The reaction mixture was stirred at 140 °C for 16 h. After cooling to room temperature, the tube was unsealed and KO*t*Bu (1 mmol) was added to the reaction mixture and stirred under open air at room temperature for 24 h. The reaction mixture was passed through a celite bed (200 nm). After concentration under reduced pressure, the residue was purified by 100--200 mesh silica-gel column chromatography using ethyl acetate/petroleum ether (1:4) to afford the pure product **1**. (In the case of aliphatic alcohols, the reaction mixture was heated for 24 h.)

### 4.3.1. 3-Benzyl-3-hydroxyindolin-2-one (**5a**)^[@ref12]^ {#sec4.3.1}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), benzyl alcohol (108 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-benzyl-3-hydroxyindolin-2-one (166 mg, 69%) as a white crystalline solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.21 (s, 1H), 7.17 (d, *J* = 7.7 Hz, 1H), 7.12 (d, *J* = 6.8 Hz, 3H), 7.02 (d, *J* = 7.4 Hz, 1H), 6.98 (t, *J* = 6.4 Hz, 3H), 6.70 (d, *J* = 7.7 Hz, 1H), 3.71 (s, 1H), 3.30 (d, *J* = 13.0 Hz, 1H), 3.12 (d, *J* = 13.0 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.69, 140.27, 133.92, 130.57, 129.84, 128.81, 128.0, 127.11, 125.10, 122.98, 110.21, 44.75. IR (neat) 3264.7, 1710.94 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~15~H~13~NO~2~ (M + Na)^+^: 262.0843, found: 262.0841.

### 4.3.2. 3-Hydroxy-3-(4-methylbenzyl)indolin-2-one (**5b**)^[@ref12]^ {#sec4.3.2}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methylbenzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-(4-methylbenzyl)indolin-2-one (130 mg, 55%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.73 (bs, 1H), 7.22--7.13 (m, 2H), 7.05--7.03 (t, 1H), 6.95--6.93 (d, *J* = 8 Hz, 2H), 6.88--6.86 (d, *J* = 8 Hz, 2H), 6.72--6.70 (d, *J* = 8 Hz 1H), 3.28--3.24 (d, *J* = 8 Hz, 1H), 3.18 (s, 1H), 3.11--3.08 (d, *J* = 12 Hz, 1H), 2.24 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.69, 140.31, 136.69, 130.72, 130.42, 129.78, 129.50, 128.79, 125.34, 125.08, 122.95, 110.19, 44.35, 21.19. IR (neat) 3320.48, 2942.83, 1729.97 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO~2~ (M + Na)^+^: 276.1000, found: 276.1000.

### 4.3.3. 3-Hydroxy-3-(3-methylbenzyl)indolin-2-one (**5c**) {#sec4.3.3}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methylbenzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-(3-methylbenzyl)indolin-2-one (114 mg, 45%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.73 (s, 1H), 7.24--7.14 (m, 2H), 7.03 (t, *J* = 8 Hz, 2H), 6.97 (d, *J* = 8 Hz, 1H), 6.83--6.75 (m, 2H), 6.72 (d, *J* = 8 Hz, 1H), 3.27 (d, *J* = 12 Hz, 1H), 3.19 (s, 1H), 3.09 (d, *J* = 12 Hz, 1H), 2.20 (s, 3H).

^13^C NMR (100 MHz, CDCl~3~) δ 179.72, 140.31, 137.59, 133.79, 131.38, 129.83, 127.88, 127.58, 125.14, 122.91, 110.19, 44.72, 21.41. IR (neat) 3262.8, 2923.89, 1715.14 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO~2~ (M + Na)^+^: 276.1000, found: 276.1000.

### 4.3.4. 3-Hydroxy-3-(2-methoxybenzyl)indolin-2-one (**5d**) {#sec4.3.4}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-methoxylbenzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-(2-methoxylbenzyl)indolin-2-one (147 mg, 55%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.46 (s, 1H), 7.26--7.22 (m, 1H), 7.18 (td, *J* = 7.7, 1.2 Hz, 1H), 6.93 (dd, *J* = 8 Hz, 2H), 6.90--6.85 (m, 2H), 6.84--6.79 (m, 2H), 4.36 (s, 1H), 3.77 (s, 3H), 3.63 (d, *J* = 13.8 Hz, 1H), 2.86 (dd, *J* = 13.8, 1.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.86, 157.86, 140.17, 132.86, 130.39, 129.36, 128.81, 125.53, 123.06, 122.36, 120.73, 110.74, 110.17, 77.66, 55.53, 38.52. IR (neat) 3256.92, 2928.24, 1715.51 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO~2~ (M + H)^+^: 270.1130, found: 270.1134.

### 4.3.5. 3-Hydroxy-3-(3-methoxybenzyl)indolin-2-one (**5e**)^[@ref12]^ {#sec4.3.5}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methoxylbenzyl alcohol (122 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-(3-methoxylbenzyl)indolin-2-one (67 mg, 25%) as a light brown solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (bs, 1H), 7.20--7.17 (m, 2H), 7.05--7.01 (m, 2H), 6.70--6.68 (m, 2H), 6.57 (m, 1H), 6.48 (m, 1H), 3.61 (s, 3H), 3.43 (bs, 1H), 3.38 (d, *J* = 12 Hz, 1H), 3.11 (d, *J* = 16 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.23, 159.08, 140.46, 135.45, 129.98, 129.80, 128.96, 125.01, 123.02, 122.98, 115.59, 113.11, 110.43, 77.69, 55.17, 44.68, 29.83. IR (neat) 3228.8, 1704.7 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~15~NO~3~ (M + Na)^+^: 292.0949, found: 292.0948.

### 4.3.6. 3-(\[1,1′-Biphenyl\]-4-ylmethyl)-3-hydroxyindolin-2-one (**5g**) {#sec4.3.6}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), biphenyl-4-methanol (184 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-(\[1,1′-biphenyl\]-4-ylmethyl)-3-hydroxyindolin-2-one (133 mg, 42%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.57--7.50 (m, 2H), 7.43--7.38 (m, 3H), 7.35--7.28 (m, 1H), 7.20 (dd, *J* = 8, 5.0 Hz, 3H), 7.11--7.01 (m, 3H), 6.72 (d, *J* = 8 Hz, 2H), 3.35 (d, *J* = 12 Hz, 1H), 3.18 (d, *J* = 12 Hz, 1H), 2.81 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 130.66, 128.55, 126.69, 126.18, 124.56, 122.35, 109.93, 77.42, 77.20, 76.78, 49.81, 49.37, 49.09, 48.83, 48.18, 48.18, 45.57, 43.58, 29.53. IR (neat) 3335.69, 1715.63, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~21~H~17~NO~2~ (M + Na)^+^: 338.1156, found: 338.1163.

### 4.3.7. 3-Hydroxy-3-isopentylindolin-2-one (**5h**)^[@ref12]^ {#sec4.3.7}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), iso-amyl alcohol (88 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-isopentylindolin-2-one (77 mg, 35%) as a pale yellow solid.

^1^H NMR (400 MHz, CDCl~3~) δ 8.77 (bs, 1H), 7.33 (d, *J* = 6.6 Hz, 1H), 7.25--7.19 (m, 1H), 7.11--7.02 (m, 1H), 6.88 (d, *J* = 7.5 Hz, 1H), 3.37 (s, 1H), 2.04--1.89 (m, 2H), 1.45 (dt, *J* = 12.9, 6.4 Hz, 1H), 1.15--0.88 (m, 2H), 0.79 (d, *J* = 6.3 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 190.73, 140.72, 129.67, 124.35, 123.24, 110.67, 36.49, 31.86, 28.21, 22.53, 22.44. IR (neat) 3389, 3680, 1711 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~13~H~17~NO~2~ (M + Na)^+^: 242.1156, found: 242.1161.

### 4.3.8. 3-Hexyl-3-hydroxyindolin-2-one (**5i**)^[@ref12]^ {#sec4.3.8}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), 1-hexanol (102 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hexyl-3-hydroxyindolin-2-one (115 mg, 48%) as a pale yellow solid. ^1^H NMR (400 MHz, CDCl~3~) δ 9.11 (s, 1H), 7.31 (d, *J* = 7.3 Hz, 1H), 7.20 (t, *J* = 7.6 Hz, 1H), 7.03 (t, *J* = 7.5 Hz, 1H), 6.86 (d, *J* = 7.7 Hz, 1H), 4.16 (s, 1H), 1.91 (dt, *J* = 13.0, 7.3 Hz, 2H), 1.14 (m, 8H), 0.80 (t, *J* = 6.9 Hz, 3H). ^13^C NMR (400 MHz, CDCl~3~) δ 181.64, 140.76, 130.98, 129.53, 124.22, 123.13, 110.70, 77.28, 38.37, 31.60, 29.39, 23.09, 22.61, 14.11. IR (neat) 3678, 3324, 1711, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~14~H~20~NO~2~ (M + H)^+^: 234.1494, found: 234.1486.

### 4.3.9. 3-Hydroxy-3-octylindolin-2-one (**5j**)^[@ref12]^ {#sec4.3.9}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), 1-hexanol (130 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-hydroxy-3-octylindolin-2-one (110 mg, 42%) as a pale yellow solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.69 (bs, 1H), 7.35--7.25 (m, 1H), 7.22--7.25 (m, 1H), 6.87 (d, *J* = 12 Hz, 1H), 2.76 (bs, 1H), 1.96--1.94 (m, 2H), 1.25--1.19 (m, 12H), 0.85 (t, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 180.31, 140.51, 130.56, 129.75, 124.46, 123.28, 110.29, 77.07, 38.72, 31.91, 29.74, 29.41, 29.28, 23.20, 22.75, 14.23. IR (neat) 3267.7, 1713.5, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~22~NO~2~ (M + Na)^+^: 284.1626, found: 284.1626.

### 4.3.10. 1-Benzyl-3-butyl-3-hydroxyindolin-2-one (**5k**) {#sec4.3.10}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), 1-butanol (74 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-butyl-3-hydroxyindolin-2-one (141 mg, 48%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.36--7.34 (d, *J* = 8 Hz, 1H), 7.30--7.27 (m, 3H), 7.25--7.20 (m, 2H), 7.17 (dt, *J* = 8 Hz, 1H), 7.03 (dt, *J* = 8 Hz, 1H), 7.69 (d, *J* = 8 Hz, 1H), 4.97 (d, *J* = 16 Hz, 1H), 4.73 (d, *J* = 16 Hz, 1H), 3.11 (s, 1H), 2.02--1.97 (m, 2H), 1.26--1.03 (m, 4H), 0.88 (t, *J =* 8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 179.03, 143.09, 135.98, 130.54, 129.24, 127.74, 124.39, 123.60, 109.19, 44.26, 38.97, 25.88, 23.18, 14.28. IR (neat) 3338.19, 2930.03, 1696.45 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~19~H~21~NO~2~ (M + Na)^+^: 318.1469, found: 318.1472.

### 4.3.11. 1-Benzyl-3-hydroxy-3-isopentylindolin-2-one (**5l**) {#sec4.3.11}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), iso-amyl alcohol (88 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-isopentylindolin-2-one (123 mg, 40%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.36 (dd, *J* = 4 Hz, 1H), 7.31--7.27 (m, 3H), 7.24--7.12 (m, 3H), 7.03 (t, *J* = 8 Hz, 1H), 6.69 (d, *J* = 8 Hz, 1H), 5.98 (d, *J* = 16 Hz, 1H), 4.73 (d, *J* = 16 Hz, 1H), 3.60 (s, 1H), 2.05--1.99 (m, 2H), 1.45--1.42 (m, 1H), 1.06--1.02 (m, 1H), 0.94--0.83 (m, 1H), 0.78 (dd, *J* = 4 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.86, 142.68, 135.64, 130.31, 129.91, 129.19, 127.78, 127.41, 124.03, 123.28, 109.53, 76.88, 43.88, 36.75, 32.17, 28.17, 22.55, 22.37. IR (neat) 3390.84, 2954.23, 1705.72 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~20~H~23~NO~2~ (M + Na)^+^: 332.1626, found: 332.1625.

### 4.3.12. 1-Benzyl-3-hydroxy-3-octylindolin-2-one (**5m**) {#sec4.3.12}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), octanol (130 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-octylindolin-2-one (115 mg, 33%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.35 (dd, *J* = 8 Hz, 1H), 7.31--7.26 (m, 2H), 7.23 (m, 3H), 7.17 (td, *J* = 8, 1.3 Hz, 1H), 7.03 (td, *J* = 8, 0.7 Hz, 1H), 6.68 (d, *J* = 8 Hz, 1H), 4.98 (d, *J* = 16 Hz, 1H), 4.72 (d, *J* = 16 Hz, 1H), 3.09 (s, 1H), 2.03--1.88 (m, 2H), 1.22--1.15 (m, 12H), 0.82 (t, *J* = 8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.71, 142.77, 135.66, 130.21, 129.62, 128.92, 127.83, 127.41, 124.06, 123.28, 109.58, 43.94, 38.91, 31.92, 29.73, 29.32, 23.44, 22.74, 14.23. IR (neat) 3377.58, 3056.27, 1704.20 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~29~NO~2~ (M + Na)^+^: 374.2095, found: 374.2097.

### 4.3.13. 1-Benzyl-3-hexyl-3-hydroxyindolin-2-one (**5n**) {#sec4.3.13}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), hexanol (103 mg, 1 mmol), N-protected-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hexyl-3-hydroxyindolin-2-one (155 mg, 48%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.35 (d, *J* = 8 Hz, 1H), 7.24--7.27 (m, 2H), 7.25--7.15 (m, 1H), 7.03 (t, *J* = 8 Hz, 3H), 6.68 (d, *J* = 8 Hz, 1H), 5.98 (d, *J* = 16 Hz, 1), 4.70 (d, *J* = 16 Hz, 1H), 3.72 (s, 1H), 2.03--1.99 (m, 2H), 1.24--1.16 (m, 8H), 0.80 (t, *J* = 8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.95, 142.69, 135.66, 130.40, 129.48, 128.86, 127.76, 127.38, 124.04, 123.24, 109.52, 76.87, 43.89, 38.85, 31.61, 29.35, 23.38, 22.53, 14.10. IR (neat) 3377.58, 3056.27, 1704.20 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~21~H~25~NO~2~ (M + H)^+^: 324.1963, found: 324.1967.

### 4.3.14. 1,3-Dibenzyl-3-hydroxyindolin-2-one (**5o**)^[@cit10a]^ {#sec4.3.14}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), benzyl alcohol (108 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1,3-dibenzyl-3-hydroxyindolin-2-one (213 mg, 65%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.41--7.36 (m, 1H), 7.22--7.05 (m, 8H), 6.97--6.92 (m, 2H), 6.71 (d, *J* = 7.1 Hz, 2H), 6.43 (d, *J* = 7.7 Hz, 1H), 5.00 (d, *J* = 16.0 Hz, 1H), 4.45 (d, *J* = 15.9 Hz, 1H), 3.44 (dd, *J* = 12.7, 2.2 Hz, 1H), 3.32 (dd, *J* = 12.7, 3.7 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 177.88, 142.81, 135.01, 133.99, 130.55, 129.86, 129.38, 128.77, 128.21, 127.43, 127.04, 126.76, 124.52, 123.11, 109.72, 77.76, 44.92, 43.84. IR (neat) 3325.90, 3031.66, 1690.12 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~22~H~19~NO (M + H)^+^: 330.1494, found: 330.1501.

### 4.3.15. 1-Benzyl-3-hydroxy-3-(2-methylbenzyl)indolin-2-one (**5p**) {#sec4.3.15}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methyl benzyl alcohol (122 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(2-methylbenzyl)indolin-2-one (195 mg, 57%) as a white solid.

^1^H NMR (400 MHz, CDCl~3~) δ 7.24--7.17 (m, 3H), 7.16--7.12 (m, 3H), 7.08 (d, *J* = 7.3 Hz, 1H), 7.04--6.95 (m, 3H), 6.88 (dd, *J* = 6.5, 3.0 Hz, 2H), 6.54 (d, *J* = 7.8 Hz, 1H), 5.05 (d, *J* = 15.9 Hz, 1H), 4.54 (d, *J* = 15.8 Hz, 1H), 3.39 (d, *J* = 13.6 Hz, 1H), 3.29 (d, *J* = 13.6 Hz, 1H), 2.93 (s, 1H), 2.10 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.23, 142.66, 137.85, 135.25, 132.53, 131.22, 130.62, 129.88, 129.57, 128.88, 127.58, 127.28, 126.91, 125.68, 124.75, 122.99, 109.61, 43.92, 41.02, 20.05. IR (neat) 3364.81, 3059.62, 1700.28, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~2~ (M + Na)^+^: 366.1469, found: 366.1462.

### 4.3.16. 1-Benzyl-3-hydroxy-3-(3-methylbenzyl)indolin-2-one (**5q**) {#sec4.3.16}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methyl benzyl alcohol (122 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(3-methylbenzyl)indolin-2-one (137 mg, 40%) as a white solid.

^1^H NMR (400 MHz, CDCl~3~) δ 7.41 (dd, *J =* 8 Hz, 1H), 7.21--7.07 (m, 5H), 7.01--6.97 (m, 2H), 6.77 (s, 1H), 7.01--6.97 (m, 3H), 6.72--6.66 (m, 1H), 6.43 (d, *J =* 12, 1H), 5.05 (d, *J =* 16 Hz, 1H), 4.42 (d, *J =* 16 Hz, 1H), 3.42 (d, *J =* 16 Hz, 1H), 3.31 (d, *J =* 12 Hz, 1H), 2.15 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.15, 142.80, 137.74, 135.02, 133.87, 131.27, 129.75, 129.55, 128.72, 128.04, 127.75, 127.54, 127.38, 126.61, 124.53, 123.08, 109.68, 77.85, 44.84, 43.82, 21.36. IR (neat) 3377.58, 1704.20 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~2~ (M + Na)^+^: 366.1469, found: 366.1475.

### 4.3.17. 1-Benzyl-3-hydroxy-3-(4-methylbenzyl)indolin-2-one (**5r**) {#sec4.3.17}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methyl benzyl alcohol (122 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(4-methylbenzyl)indolin-2-one (189 mg, 55%) as a white solid.

^1^H NMR (400 MHz, CDCl~3~) δ 7.42 (dd, *J* = 7.2, 1.1 Hz, 1H), 7.19--7.01 (m, 5H), 6.92 (d, *J* = 8 Hz, 2H), 6.83 (d, *J* = 8.0 Hz, 2H), 6.72 (d, *J* = 8 Hz, 2H), 6.46--6.40 (m, 1H), 5.05 (d, *J* = 16.0 Hz, 1H), 4.41 (d, *J* = 16.0 Hz, 1H), 4.09 (s, 1H), 3.42 (d, *J* = 12.7 Hz, 1H), 3.34 (d, *J* = 12.7 Hz, 1H), 2.29 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.19, 142.79, 136.44, 135.03, 130.88, 130.40, 129.71, 129.61, 128.87, 128.60, 127.37, 126.81, 124.50, 123.08, 109.66, 77.83, 44.42, 43.83, 21.25. IR (neat) 3292.61, 2943.54, 1737.98, cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~2~ (M + H)^+^: 344.1650, found: 344.1652.

### 4.3.18. 1-Benzyl-3-(2-methoxybenzyl)indoline (**5s**) {#sec4.3.18}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-methoxy benzyl alcohol (138 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(2-methoxylbenzyl)indolin-2-one (183 mg, 51%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.29 (dd, *J* = 8.8, 2.5 Hz, 2H), 7.24 (dd, *J* = 4.6, 3.6 Hz, 2H), 7.17--7.09 (m, 3H), 6.97 (dd, *J* = 14.8, 8.0, Hz, 3H), 6.85 (t, *J* = 7.1 Hz, 2H), 6.59 (d, *J* = 7.8 Hz, 1H), 5.04 (d, *J* = 15.8 Hz, 1H), 4.66 (d, *J* = 15.9 Hz, 1H), 3.74--3.70 (m, 5H), 2.97 (d, *J* = 16 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.61, 157.86, 142.31, 135.59, 132.59, 129.27, 129.06, 128.47, 128.18, 127.43, 127.09, 125.07, 122.97, 122.45, 120.60, 110.68, 109.22, 108.81, 55.31, 43.82, 38.46. IR (neat) 3375.29, 1708.59 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~3~ (M + Na)^+^: 382.1418, found: 382.1418.

### 4.3.19. 1-Benzyl-3-hydroxy-3-(4-methoxybenzyl)indolin-2-one (**5t**) {#sec4.3.19}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methoxy benzyl alcohol (138 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(4-methoxylbenzyl)indolin-2-one (179 mg, 50%) as a green solid.

^1^H NMR (400 MHz, CDCl~3~) δ 7.41--7.40 (d, *J* = 12 Hz, 1H), 7.34--7.30 (m, 1H), 7.16--7.08 (m, 4H), 6.82 (d, *J* = 8 Hz, 2H), 6.67--6.61 (m, 4H), 6.44--6.42 (m, *J* = 8 Hz, 1H), 5.05 (d, *J* = 8 Hz, 1H), 4.05 (s, 1H), 4.40 (d, *J* = 16 Hz, 1H), 3.72 (s, 3H), 3.40--3.37 (d, *J* = 12 Hz, 1H), 3.30--3.27 (d, *J* = 12 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.35, 158.72, 142.77, 135.15, 131.51, 129.78, 129.60, 128.7, 127.45, 126.97, 126.74, 125.96, 124.45, 123.19, 113.63, 109.47, 77.97, 55.16, 43.93, 43.68. IR (neat) 1703.34, 2924.12, 3369.49 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~3~ (M + Na)^+^: 382.1418, found: 382.1423.

### 4.3.20. 1-Benzyl-3-hydroxy-3-(3-methoxybenzyl)indolin-2-one (**5u**) {#sec4.3.20}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methoxy benzyl alcohol (138 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-hydroxy-3-(3-methoxylbenzyl)indolin-2-one (168 mg, 47%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.42 (dd, *J* = 8, 1.2 Hz, 1H), 7.21--7.08 (m, 5H), 7.02 (d, *J* = 8 Hz, 1H), 6.75 (d, *J* = 2.4 Hz, 1H), 6.74--6.69 (m, 2H), 6.57 (d, *J* = 8 Hz, 1H), 6.44 (d, *J* = 8 Hz, 1H), 6.42--6.40 (m, 1H), 5.03 (d, *J* = 16.0 Hz, 1H), 4.43 (d, *J* = 16.0 Hz, 1H), 3.64 (s, 1H), 3.52 (s, 3H), 3.42 (d, *J* = 12 Hz, 1H), 3.32 (d, *J* = 12.7 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 177.86, 159.31, 142.94, 135.41, 135.02, 129.86, 129.48, 129.17, 128.79, 127.46, 126.68, 124.49, 123.03, 115.12, 113.58, 109.76, 77.69, 55.13, 44.97, 43.85. IR (neat) 1705.13, 2922.32, 3380.04 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~21~NO~3~ (M + H)^+^: 360.1599, found: 360.1607.

### 4.3.21. 3-(\[1,1′-Biphenyl\]-4-ylmethyl)-1-benzylindolin-3-ol (**5v**) {#sec4.3.21}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-methoxy biphenyl-4-methanol (185 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-(\[1,1′-biphenyl\]-4-ylmethyl)-1-benzylindolin-3-ol (182 mg, 45%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.55 (dd, 2H), 7.44--7.33 (m, 6H), 7.06--7.00 (m, 7H), 6.73 (d, *J =* 8 Hz, 2H), 6.45 (d, *J =* 8 Hz, 1H), 5.06 (d, *J =* 16 Hz, 1H), 4.44 (d, *J =* 12 Hz, 1H), 3.49 (d, *J =* 12 Hz, 1H), 3.37 (d, *J =* 16 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 177.89, 142.88, 140.64, 139.77, 134.97, 133.08, 130.99, 129.94, 129.37, 128.83, 127.44, 127.04, 126.76, 124.53, 123.17, 109.83, 77.69, 44.57, 43.93. IR (neat) 3373.14, 1701.55 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~28~H~23~NO~2~ (M + H)^+^: 406.1807, found: 406.1814.

### 4.3.22. 1-Benzyl-3-(3-bromobenzyl)-3-hydroxyindolin-2-one (**5w**) {#sec4.3.22}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-bromobenzyl alcohol (185 mg, 1 mmol), *N*-benzyl-2-oxindole (446 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 1-benzyl-3-(3-bromobenzyl)-3-hydroxyindolin-2-one (204 mg, 50%) as a yellow solid. ^1^H NMR (400 MHz, CDCl~3~) δ 7.80 (d, *J* = 12 Hz, 1H), 7.35--7.29 (m, 2H), 7.24--7.18 (m, 5H), 7.04 (d, *J* = 8 Hz, 2H), 6.80 (d, *J* = 8 Hz, 1H), 6.53 (d, *J* = 8 Hz, 1H), 5.10 (d, *J* = 16 Hz, 1H), 4.53 (d, *J* = 16 Hz, 1H), 4.23 (bs, 1H), 3.55 (d, *J* = 12 Hz, 1H), 3.46 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 178.05, 142.67, 134.82, 133.93, 132.10, 131.19, 130.44, 129.69, 129.40, 128.88, 128.43, 128.72, 128.08, 127.50, 127.31, 126.90, 126.65, 124.39, 123.10, 109.67, 77.62, 44.80, 43.78. IR (neat) 3367.99, 2923.16, 1708.46 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~22~H~18~BrNO~2~ (M + H)^+^: 408.0599, found: 408.0597.

### 4.3.23. 3-Benzyl-6-chloro-3-hydroxyindolin-2-one (**5a′**) {#sec4.3.23}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), benzyl alcohol (108 mg, 1 mmol), 6-chloro-2-oxindole (335 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford **3**-benzyl-6-chloro-3-hydroxyindolin-2-one **5a′** (158 mg, 58%) as a white solid. ^1^H NMR \[400 MHz, CDCl~3~ + CD~3~CN (3:2)\] δ 8.00 (s, 1H), 6.92 (d, *J* = 1.5 Hz, 3H), 6.75 (dd, *J* = 19.9, 6.2 Hz, 4H), 6.48 (s, 1H), 3.81 (s, 1H), 3.00 (d, *J* = 12.8 Hz, 1H), 2.85 (d, *J* = 13.0 Hz, 1H). ^13^C NMR \[100 MHz, CDCl~3~ + CD~3~CN (3:2)\] δ 179.08, 142.75, 134.83, 134.64, 130.74, 129.13, 128.15, 127.13, 126.34, 122.19, 110.54, 77.04, 44.12. IR (neat) 3315.14, 2943.04, 1665.53 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~15~H~12~ClNO~2~ (M + Na)^+^: 274.0635, found: 274.0629.

### 4.3.24. 6-Chloro-3-hydroxy-3-(4-methylbenzyl)indolin-2-one (**5b′**) {#sec4.3.24}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methyl-benzyl alcohol (122 mg, 1 mmol), 6-chloro-2-oxindole (335 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 6-chloro-3-hydroxy-3-(4-methylbenzyl)indolin-2-one **5b′** (160 mg, 56%) as a white solid. ^1^H NMR \[400 MHz, CDCl~3~ + CD~3~OD (3:2)\] δ 7.02 (dd, *J* = 7.8, 4.2 Hz, 1H), 6.93 (d, *J* = 7.9 Hz, 1H), 6.89 (d, *J* = 7.6 Hz, 2H), 6.80 (d, *J* = 7.4 Hz, 2H), 6.66 (s, 1H), 4.31 (bs, 1H), 3.18 (d, *J* = 12.9 Hz, 1H), 3.03 (d, *J* = 12.9, 1H), 2.20 (s, 3H). ^13^C NMR \[100 MHz, CDCl~3~ + CD~3~OD (3:2)\] δ 180.85, 142.78, 136.67, 135.19, 131.28, 130.51, 129.39, 128.82, 126.01, 122.45, 110.92, 43.80, 21.08. IR (neat) 3323.12, 2942.22, 1663.50 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~14~ClNO~2~ (M + H)^+^: 288.0791, found: 288.0783.

### 4.3.25. 3-(\[1,1′-Biphenyl\]-4-ylmethyl)-6-chloro-3-hydroxyindolin-2-one (**5c′**) {#sec4.3.25}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), biphenyl methanol (184 mg, 1 mmol), 6-chloro-2-oxindole (335 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-(\[1,1′-biphenyl\]-4-ylmethyl)-6-chloro-3-hydroxyindolin-2-one **5c′** (174 mg, 50%) as a yellow solid. ^1^H NMR \[400 MHz, CDCl~3~ + CD~3~OD (3:2)\]: δ 7.49 (d, *J* = 6.8 Hz, 2H), 7.35 (d, *J* = 7.7 Hz, 4H), 7.27 (d, *J* = 6.9 Hz, 1H), 7.08 (d, *J* = 7.8 Hz, 1H), 7.04--6.93 (m, 3H), 6.68 (s, 1H), 3.27 (d, *J* = 12.9 Hz, 1H), 3.12 (d, *J* = 12.8 Hz, 1H). ^13^C NMR \[100 MHz, CDCl~3~ + CD~3~OD (3:2)\] δ 180.92, 143.15, 141.23, 140.16, 135.48, 133.85, 131.32, 129.22, 127.69, 127.31, 126.87, 126.22, 122.67, 111.13, 77.71, 44.02. IR (neat) 3339.14, 2947.04, 1670.53 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~21~H~16~ClNO~2~ (M + H)^+^: 350.0948, found: 350.0940.

### 4.3.26. 3-Butyl-6-chloro-3-hydroxyindolin-2-one (**5d′**) {#sec4.3.26}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 1-butanol (74 mg, 1 mmol), 6-chloro-2-oxindole (334 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-butyl-6-chloro-3-hydroxyindolin-2-one **5d′** (119 mg, 50%) as a white solid. ^1^H NMR (400 MHz, CD~3~OD) δ 7.28 (d, *J* = 7.9 Hz, 1H), 7.05 (d, *J* = 8.0 Hz, 1H), 6.91 (s, 1H), 1.95--1.87 (m, 2H), 1.26 (dt, *J* = 14.4, 7.2 Hz, 2H), 1.16--0.91 (m, 2H), 0.83 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CD~3~OD) δ 182.07 (s), 144.26 (s), 135.87 (s), 131.59 (s), 126.18 (s), 123.40 (s), 111.53 (s), 77.51 (s), 38.55 (s), 26.46 (s), 23.77 (s), 14.17 (s). IR (neat) 1708.33, 2830.98, 3317.44 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~12~H~14~ClNO~2~ (M + H)^+^: 240.0791, found: 240.0797.

### 4.3.27. 6-Chloro-3-hydroxy-3-octylindolin-2-one (**5e′**) {#sec4.3.27}

Ru-NHC complex (12 mg, 0.02 mmol), KO*t*Bu (258 mg, 2.3 mmol), 1-octanol (130 mg, 1 mmol), 6-chloro-2-oxindole (335 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 6-chloro-3-hydroxy-3-octylindolin-2-one **5e′** (171 mg, 58%) as a white solid. ^1^H NMR \[400 MHz, CDCl~3~ + CD~3~CN (3:2)\] δ 7.28 (d, *J* = 2.3 Hz, 1H), 7.06 (dd, *J* = 7.9, 1.7 Hz, 1H), 6.91 (d, *J* = 1.6 Hz, 1H), 2.08--1.86 (m, 2H), 1.27 (m, 12H), 0.86 (t, *J* = 8 Hz, 3H). ^13^C NMR \[100 MHz, CDCl~3~ + CD~3~CN (3:2)\] δ 180.17, 143.53, 134.89, 130.97, 126.03, 122.75, 110.97, 76.72, 38.28, 32.25, 30.00, 29.62, 23.59, 23.09, 14.14. IR (neat) 3319.13, 2941.56, 1618.82 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~16~H~22~ClNO~2~ (M + H)^+^: 296.1417, found: 296.1408.

### 4.3.28. 2-Benzyl-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (**7a**)^[@cit10a]^ {#sec4.3.28}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), benzyl alcohol (108 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-benzyl-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (173 mg, 69%) as a white crystalline solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.04--8.02 (d, *J* = 8 Hz, 1H), 7.59--7.55 (dt, 1H), 7.39 (t, *J* = 8 Hz, 1H), 7.32--7.28 (m, 3H), 7.15 (d, *J* = 4 Hz, 2H), 3.78 (s, 1H), 3.31--3.23 (m, 1H), 3.02--2.91 (m, 3H), 2.27--2.19 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.98, 143.28, 135.42, 134.23, 130.45, 129.21, 128.19, 128.09, 127.16, 126.96, 76.13, 42.02, 33.90, 26.46. IR (neat) 1683.26, 3028.36, 3477.34 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~17~H~16~O~2~ (M + Na)^+^: 275.1047, found: 275.1047.

### 4.3.29. 2-Hydroxy-2-(4-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7b**) {#sec4.3.29}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methylbenzyl alcohol (122 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford **2-**hydroxy-2-(4-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (143 mg, 53%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.03 (d, *J* = 8 Hz, 1H), 7.55 (dt, 1H), 7.41 (t, *J* = 8 Hz, 1H) 7.31 (d, *J* = 8 Hz, 1H), 7.12--7.03 (m, 2H), 3.75 (s, 1H), 3.30--3.22 (m, 1H), 3.07--2.87 (m, 3H), 2.32 (s, 1H), 2.29--2.17 (m, 3H), 2.20 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) 201.09, 143.33, 136.53, 134.22, 132.26, 130.34, 129.23, 128.96, 128.11, 127.17, 76.20, 41.64, 33.95, 26.51, 21.22. IR (neat) 3490.89, 2929.83, 1685.79 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~2~ (M + Na)^+^: 289.1204, found: 289.1205.

### 4.3.30. 2-Hydroxy-2-(3-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7c**) {#sec4.3.30}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-methylbenzyl alcohol (122 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-hydroxy-2-(3-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (138 mg, 52%) as a yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.03 (d, *J* = 8 Hz, 1H), 7.57 (dt, 1H), 7.39 (d, *J* = 8 Hz, 1H), 7.31 (d, *J* = 8 Hz, 1H), 7.16 (t, *J* = 8 Hz, 1H), 7.06 (d, *J* = 8 Hz, 1H), 6.99 (s, 1H), 6.93 (d, *J* = 8 Hz, 1H), 3.77 (s, 1H), 3.31--3.22 (m, 1H), 3.07--2.87 (m, 3H), 2.32 (s, 3H), 2.27--2.15 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 201.06, 143.34, 137.75, 135.36, 134.22, 131.35, 130.60, 129.24, 128.11, 128.09, 127.77, 127.45, 127.18, 76.20, 42.01, 33.93, 26.53, 21.56.

IR (neat) 3499.89, 3052.54, 2940.83, 1734.65 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~2~ (M + Na)^+^: 289.1204, found: 289.1205.

### 4.3.31. 2-Hydroxy-2-(2-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7d**) {#sec4.3.31}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-methylbenzyl alcohol (122 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford **2-**hydroxy-2-(2-methylbenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (133 mg, 50%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.03 (dd, *J* = 7.8, 1.3 Hz, 1H), 7.57 (td, *J* = 7.5, 1.4 Hz, 1H), 7.39 (t, *J* = 7.6 Hz, 1H), 7.32 (d, *J* = 7.8 Hz, 1H), 7.15--7.05 (m, 3H), 6.96 (d, *J* = 7.2 Hz, 1H), 3.71 (s, 1H), 3.32 (ddd, *J* = 18.0, 12.8, 5.3 Hz, 1H), 3.15 (d, *J* = 14.0 Hz, 1H), 3.12--3.06 (m, 1H), 3.01 (d, *J* = 13.9 Hz, 1H), 2.48--2.41 (m, 1H), 2.35--2.25 (m, 1H), 2.20 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.78, 143.21, 137.97, 134.23, 133.56, 131.16, 130.58, 129.26, 128.20, 127.26, 127.05, 125.52, 76.68, 38.54, 35.43, 26.58, 20.29.

IR (neat) 1643.9 cm^--1^; IR = 1686.44, 2935.29, 3496.45 cm^--1^

HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~2~ (M + Na)^+^: 289.1204, found: 289.1201.

### 4.3.32. 2-Hydroxy-2-(2-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7e**) {#sec4.3.32}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-methoxybenzyl alcohol (138 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-hydroxy-2-(2-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (126 mg, 45%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.03--8.01 (dd, 1H), 7.56--7.52 (dt, 1H), 7.37 (t, *J* = 8 Hz, 1H), 7.32--7.27 (m, 2H), 7.24 (dd, *J* = 8 Hz, 1H), 6.93 (td, 8 Hz, 1.3 Hz, 1H), 6.78 (d, *J* = 8 Hz, 3H), 3.74 (s, 1H), 3.50 (s, 1H), 3.44--3.38 (m, 2H), 3.08--3.01 (m, 1H), 2.86 (d, *J* = 16 Hz, 1H), 2.34--2.28 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.12, 157.46, 143.23, 133.64, 132.97, 131.12, 129.10, 128.42, 127.89, 126.66, 123.46, 120.37, 110.06, 75.96, 54.66, 36.31, 35.30, 26.50. IR (neat) 1737.51, 2930.57, 3501.29 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~3~ (M + Na)^+^: 305.1153, found: 305.1158.

### 4.3.33. 2-Hydroxy-2-(4-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7f**) {#sec4.3.33}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methoxybenzyl alcohol (138 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-hydroxy-2-(4-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (118 mg, 42%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.02 (d, *J* = 8 Hz, 1H), 7.56 (td, *J* = 7.5, 1.4 Hz, 1H), 7.38 (t, *J* = 7.6 Hz, 1H), 7.31 (d, *J* = 7.7 Hz, 1H), 7.07 (d, *J* = 8.6 Hz, 2H), 6.81 (d, *J* = 8.6 Hz, 2H), 3.79 (s, 3H), 3.76 (s, 1H), 3.30--3.21 (m, 1H), 3.06 (dd, *J* = 5.5, 2.0 Hz, 1H), 2.91 (q, *J* = 14.0 Hz, 2H), 2.32--2.14 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 201.16, 158.68, 143.33, 134.23, 131.43, 130.55, 129.24, 128.09, 127.38, 127.18, 113.68, 76.23, 55.31, 41.20, 33.89, 26.50. IR (neat) 3493.35, 3610.31, 1735.43 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~3~ (M + Na)^+^: 305.1153, found: 305.1151.

### 4.3.34. 2-Hydroxy-2-(4-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (**7g**) {#sec4.3.34}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 4-methoxybenzyl alcohol (138 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-hydroxy-2-(4-methoxybenzyl)-3,4-dihydronaphthalen-1(2*H*)-one (116 mg, 41%) as a pale yellow liquid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.02 (d, *J* = 8 Hz, 1H), 7.56 (dt, 1H), 7.38 (t, 1H), 7.30 (d, 1H), 7.18 (t, 1H), 6.80--6.71 (m, 3H), 3.81 (s, 1H), 3.77 (s, 3H), 3.25--3.21 (m, 1H), 3.07--2.88 (m, 3H), 2.30--2.17 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.95, 159.37, 143.28, 136.99, 134.24, 130.50, 129.17, 128.07, 127.17, 122.80, 116.17, 112.40, 76.16, 55.21, 42.09, 33.91, 26.49. IR (neat) 3490.48, 2935.56, 1686.32 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~18~H~18~O~3~ (M + Na)^+^: 305.1153, found: 305.1161.

### 4.3.35. 2-(\[1,1′-Biphenyl\]-4-ylmethyl)-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (**7h**) {#sec4.3.35}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), biphenyl-4-methanol (185 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-(\[1,1′-biphenyl\]-4-ylmethyl)-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (112 mg, 34%) as an orange crystalline solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.07 (dd, *J* = 8 Hz, 1H), 7.61--7.57 (m, 3H), 7.52 (d, *J* = 8 Hz, 2H), 7.46--7.41 (m, 4H), 7.35--7.33 (m, 2H), 7.24 (s, 1H), 3.85 (s, 1H), 3.31--3.26 (m, 1H), 3.09--2.97 (m, 3H), 2.36--2.19 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 201.06, 143.36, 134.55, 134.33, 130.92, 129.29, 128.85, 128.17, 127.17, 76.23, 41.70, 33.92, 26.54. IR (neat) 3456.99, 3029.72, 1677.58 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~23~H~20~O~2~ (M + Na)^+^: 351.1360, found: 351.1367.

### 4.3.36. 2-Benzyl-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (**7i**) {#sec4.3.36}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 3-bromobenzyl alcohol (185 mg, 1 mmol), α-tetralone (292 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 2-benzyl-2-hydroxy-3,4-dihydronaphthalen-1(2*H*)-one (168 mg, 48%) as a white solid. ^1^H NMR (400 MHz, CDCl~3~) δ 8.02--7.98 (m, 1H), 7.57--7.53 (m, 1H), 7.38--7.36 (m, 2H), 7.29 (d, *J* = 8 Hz, 1H), 7.23--7.21 (m, 1H), 7.13 (dd, 1H), 7.00 (d, *J* = 12 Hz, 1H), 3.79--3.77 (d, *J* = 8 Hz, 1H), 3.25--3.18 (m, 1H), 3.00--2.88 (m, 3H), 2.26--2.17 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.77, 143.22, 135.46, 134.39, 132.15, 131.32, 130.50, 129.29, 128.22, 127.24, 126.99, 121.10, 75.96, 42.06, 33.96, 26.48. IR (neat) 3486.50, 2926.78, 1684.39 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~17~H~15~BrO~2~ (M + H)^+^: 331.0333, found: 331.0330.

### 4.3.37. (8*R*,9*S*,13*S*,14*S*)-16-Benzyl-16-hydroxy-3-methoxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17*H*-cyclopenta\[*a*\]phenanthren-17-one (**7j**) {#sec4.3.37}

Ru-NHC complex (1.5 mg, 0.0025 mmol), KO*t*Bu (64 mg, 0.57 mmol), benzyl alcohol (27 mg, 0.25 mmol), and estron 3-methyl ether (71 mg 0.25 mmol) were allowed to react in a 20 mL resealable pressure tube according to method C to afford the product **7j** (37 mg, 38%) as a colorless thick liquid with a mixture of diastereoisomers based on ^1^H NMR spectra. Selected spectral data for major diastereoisomer: ^1^H NMR (400 MHz, CDCl~3~) δ 7.30 (d, *J* = 7.1 Hz, 3H), 7.24--7.17 (m, 3H), 6.75--6.69 (m, 1H), 6.63 (d, *J* = 1.6 Hz, 1H), 3.78 (d, *J* = 0.8 Hz, 3H), 3.42 (d, *J* = 8 Hz, 1H), 2.95--2.81 (m, 3H), 2.70 (dd, *J* = 12, 8 Hz, 1H), 2.35--2.14 (m, 3H), 1.97--1.78 (m, 4H), 1.59--1.45 (m, 3H), 0.81 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 157.56, 141.43, 138.08, 132.76, 128.91, 128.55, 126.41, 126.14, 113.94, 111.59, 87.79, 55.32, 48.33, 45.63, 44.20, 41.73, 38.65, 36.98, 30.12, 29.91, 27.39, 26.33, 12.06. IR (neat) 3386.18, 2923.78, 1736.89 cm^--1^; HRMS (ESI) *m*/*z* calculated for C~26~H~31~O~3~ (M + H)^+^: 391.2273, found: 391.2272.

### 4.3.38. (8*R*,9*S*,13*S*,14*S*)-16-(4-Fluorobenzyl)-16-hydroxy-3-methoxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-17*H*-cyclopenta\[*a*\]phenanthren-17-one (**7k**) {#sec4.3.38}

Ru-NHC complex (1.5 mg, 0.0025 mmol), KO*t*Bu (64 mg, 0.57 mmol), 4-fluorobenzyl alcohol (32 mg, 0.25 mmol), and estron 3-methyl ether (71 mg, 0.25 mmol) were allowed to react in a 20 mL resealable pressure tube according to method C to afford the product **7k** (33 mg, 32%) as a colorless liquid with a mixture of diastereoisomers based on ^1^H NMR spectra. Selected spectral data for major diastereoisomer: ^1^H NMR (400 MHz, CDCl~3~) δ 7.20--7.14 (m, 3H), 6.99--6.95 (m, 2H), 6.70 (d, *J* = 2.7 Hz, 1H), 6.63 (d, *J* = 2.4 Hz, 1H), 3.77 (s, 3H), 3.40 (d, *J* = 7.6 Hz, 1H), 2.95--2.80 (m, 5H), 2.36--2.21 (m, 3H), 1.94--1.86 (m, 2H), 1.43--1.51 (m, 4H), 0.81 (bs, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 157.59, 138.10, 137.10, 132.70, 130.44, 130.03, 126.42, 115.34, 115.11, 113.95, 111.61, 87.74, 55.35, 48.34, 45.68, 44.21, 40.80, 38.66, 36.95, 29.93, 27.39, 26.33, 18.10, 12.04. IR (neat) 3373.19, 2922.76, 1732.07 cm^--1^.

HRMS (ESI) *m*/*z* calculated for C~26~H~29~FO~3~ (M + H)^+^: 409.2179, found: 409.2200.

### 4.3.39. 3-(2-(Benzyloxy)ethyl)-3-hydroxyindolin-2-one (**9**) {#sec4.3.39}

Ru-NHC complex (6 mg, 0.01 mmol), KO*t*Bu (258 mg, 2.3 mmol), 2-(benzyloxy)ethan-1-ol (154 mg, 1 mmol), oxindole (266 mg, 2 mmol), and toluene (2 mL) were allowed to react in a 20 mL resealable pressure tube according to method C to afford 3-(2-(benzyloxy)ethyl)-3-hydroxyindolin-2-one (175 mg, 60%) as a white solid. ^1^H NMR (400 MHz, acetone-*d*~6~) δ 9.24 (bs, 1H), 7.31--7.20 (m, 7H), 7.00 (td, *J* = 8, 1H), 6.89 (d, *J* = 8 Hz, 1H), 4.94 (s, 1H), 4.41--4.34 (m, 2H), 3.54--3.50 (m, 2H), 2.29--2.23 (m, 1H), 2.21--2.19 (m, 1H). ^13^C NMR (100 MHz, acetone-*d*~6~) δ 179.65, 142.79, 139.62, 132.48, 130.00, 129.00, 128.26, 128.09, 125.16, 122.70, 110.56, 75.81, 73.35, 66.69, 38.52. IR (neat) 3308.42, 2943.61, 1658.16 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~21~H~17~NO~2~ (M + Na)^+^: 306.1106, found: 306.1102.

### 4.3.40. Experimental Procedure for Hydrogenation of 3-(2-(Benzyloxy)ethyl)-3-hydroxyindolin-2-one (**9**)^[@ref15]^ {#sec4.3.40}

5% palladium on carbon was added to a 100 mL RB flask containing 3-(2-(benzyloxy)ethyl)-3-hydroxyindolin-2-one (1 mmol, 283 mg). The system was purged with nitrogen and methanol (10 mL) was added. The mixture was then charged with hydrogen using a hydrogen-balloon and hydrogenated overnight. The reaction was diluted with DCM (30 mL) and filtered through celite. The filter cake was washed well with 1:1 MeOH--DCM (2 × 10 mL). The filtrate was concentrated under vacuum to obtain 3-hydroxy-3-(2-hydroxyethyl)indolin-2-one (173 mg, 90%) as a colorless thick liquid.

### 4.3.41. 3-Hydroxy-3-(2-hydroxyethyl)indolin-2-one (**10**)^[@ref16]^ {#sec4.3.41}

Colorless liquid, yield: 90%. ^1^H NMR (400 MHz, CDCl~3~) δ 7.33 (d, *J* = 4 Hz, 1H), 7.25 (td, *J* = 8, 1 Hz, 1H), 7.05 (t, *J* = 8 Hz, 1H), 6.89 (d, *J* = 8 Hz, 1H), 3.51 (t, *J* = 8 Hz, 2H), 3.35 (s, 1H), 2.24--2.11 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 181.99, 142.66, 132.70, 130.56, 125.12, 123.65, 111.26, 76.43, 58.41, 41.21. IR (neat) 3309.16, 2943.66, 1718.32 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~10~H~11~NO~3~ (M + Na)^+^: 216.0636, found: 216.0642.

### 4.3.42. Experimental Procedure for Amination of 3-Hydroxy-3-(2-hydroxyethyl)indolin-2-one (**11**)^[@ref16]^ {#sec4.3.42}

Triethylamine (2 mL) and *p*-toluenesulfonyl chloride (1 mmol, 190 mg) were added to 3-hydroxy-3-(2-hydroxyethyl)indolin-2-one (1 mmol, 193 mg) (**10**) in a solution of DCM (2 mL) and stirred for 6 h at room temperature. The reaction mixture was poured into a mixture of ice and 5% aqueous HCl (100 mL) and extracted with EtOAc. The extract was washed with brine, dried, and evaporated. The crude reaction mixture was added to a 30% solution of methylamine in EtOH (20 mL), and the mixture was stirred under reflux for 5 h. The volatiles were evaporated, H~2~O was added, and the mixture was extracted with EtOAc. The organic extract was washed with saturated aqueous NaHCO~3~, dried over Na~2~SO~4~, and evaporated. Further, the crude reaction mixture was purified by column chromatography to afford Donaxaridine (**11**) (154 mg, 75%) as a yellow crystalline solid.

### 4.3.43. 3-Hydroxy-3-(2-(methylamino)ethyl)indolin-2-one (**11**)^[@ref16]^ {#sec4.3.43}

White solid, yield: 75%; ^1^H NMR (400 MHz, CDCl~3~) δ 7.08 (td, *J* = 7.9, 1.5 Hz, 1H), 6.83 (dd, *J* = 7.7, 1.4 Hz, 1H), 6.71--6.63 (m, 2H), 4.68 (s, 2H), 3.26 (dtd, *J* = 16.0, 9.8, 4.0 Hz, 2H), 2.93 (s, 3H), 2.74--2.67 (m, 1H), 2.44--2.37 (m, 1H).

^13^C NMR (100 MHz, CDCl~3~) δ 175.36, 145.97, 129.21, 125.80, 125.22, 118.27, 118.04, 79.54, 45.78, 33.06, 30.26.

IR (neat) 3335.40, 3057.98, 2923.49, 1668.58 cm^--1^. HRMS (ESI) *m*/*z* calculated for C~11~H~14~N~2~O~2~ (M + H)^+^: 207.1133, found: 207.1132.

4.4. Experimental Procedure for Mass Study of Intermediate G {#sec4.4}
------------------------------------------------------------

Ru-NHC (6.05 mg, 0.01 mmol), KO*t*Bu (146 mg, 1.3 mmol), benzyl alcohol (108 mg, 1.0 mmol), and 2-oxindole (266 mg, 2.0 mmol) were added to a 20 mL glass tube under a N~2~ atmosphere. Then, the tube was purged with N~2~ and sealed with a cap using a crimper. The reaction mixture was stirred at 140 °C for 16 h. After cooling to room temperature, the tube was unsealed, and KO*t*Bu (1 mmol) was added to the reaction mixture and stirred under open air at room temperature for 4 h. Further, the crude reaction mixture was frozen using liquid N~2~ and immediately directly injected into the HRMS instrument. HRMS (ESI) *m*/*z* calculated for C~15~H~13~NO~3~ (M + K)^+^: 294.0533, found: 294.0537
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